nct_id,brief_title,page_rank_score_brief_title,page_rank_score_brief_title_summary_combined
NCT01728181,A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation,0.0006786751924490412,0.0007832695072991151
NCT01731587,Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer,0.0006034918663793187,0.0006767295448317833
NCT01710319,Mechanisms of Immunosurveillance for Lung Cancer,0.0008986078023327953,0.0005924571494230052
NCT01752101,Identification of a Plasma Proteomic Signature for Lung Cancer,0.000522939939794317,0.0004778523683217434
NCT01752647,CT Screening For Lung Cancer in High Risk Patients: the Russian Study.,0.0007182345995100886,0.0005587073073487146
NCT01788566,A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer,0.000534423945678849,0.0006066864961750357
NCT01748981,"Fitness, Activity and Lung Cancer Study",0.0007738628989023345,0.00044504723909656206
NCT01770795,A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer,0.0007014956228635082,0.0006833600813875585
NCT01727076,"Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer",0.0007406467633334323,0.0008001071145745225
NCT01744925,Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR,0.0008395742481165675,0.0009493695715758037
NCT01767974,Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer,0.0007033377391306237,0.0005835162931568549
NCT01755624,Effect of TTFields (150kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-5 Brain Metastases Following Optimal Standard Local Treatment (COMET),0.0007487911435141622,0.0007180545725330486
NCT01707888,VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer,0.0006196122976008593,0.0008031366273145245
NCT01741155,Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC),0.0006829463320839032,0.0008232673667027453
NCT01741506,Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer,0.0005782367764347695,0.0005256705344017729
NCT01737112,99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients,0.000722544267241651,0.0005937097722814299
NCT01789892,Methylprednisolone Before Fludeoxyglucose-Labeled Positron Emission Tomography in Patients With Lung Cancer,0.0005919277389977091,0.0005702455744265139
NCT01721759,Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens,0.0008217916208926808,0.0007255112178269462
NCT01749072,Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients,0.0007063772342697205,0.000685949725889528
NCT01719068,Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos,0.0005241352204934023,0.0004222581151149159
NCT01724801,Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer,0.0006945469279440611,0.0005312983068019325
NCT01743586,Respiratory Muscle Function Changes and Effects of Chest Physiotherapy Education Interventionin Advanced Lung Cancer,0.0004705659969332576,0.0005134035114342264
NCT01771796,Training Effects Following Resection Surgery in Patients With Lung Cancer,0.0006530742557455694,0.0005870104070494111
NCT01778920,Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA),0.00043781489996050225,0.0006643436158970123
NCT01708954,Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer,0.0007371237453737092,0.000829377925309608
NCT01797913,The Study of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer,0.0007565090006965732,0.001063288870877463
NCT01799980,Evaluation of Endobronchial Ultrasound (EBUS) for Staging Lung Cancer,0.0006575606294734104,0.0005560674812070605
NCT01799395,Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer,0.0006011220408774614,0.0005168896705874363
NCT01720186,Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung Cancer,0.00044169650898154576,0.0004989386237409095
NCT01720836,Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer,0.0006357703212012656,0.0006222279410908303
NCT01772797,Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer,0.0010459577960904261,0.0009350511870480212
NCT01796288,The Value of Radiotherapy in the Oligometastatic Non-squamous Non-small Cell Lung Cancer With Clinical Benefits From Erlotinib as Second-line Treatment,0.0006395403359644604,0.0007353090394688592
NCT01763671,Paclitaxel-bevacizumab in Advanced Lung Cancer,0.0006300432546257357,0.0006173311461529616
NCT01793155,"Effects of Inspiratory Muscle Training After Lung Cancer Surgery, a Randomized Controlled Trial",0.0004512273335479499,0.0004920008849478386
NCT01705184,Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.,0.00048760261986006157,0.0004362034125946228
NCT01757158,Cesium-131 Seed Brachytherapy Plus Subtotal Resection for Lung Cancer Patients,0.0005820003768837503,0.000758616225645869
NCT01781741,Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Stage III-IV Non-small Cell Lung Cancer,0.0007625850002282272,0.0007560351323000369
NCT01781988,Personalized Therapy in Non-small Cell Lung Cancer,0.0009727725485424967,0.0006469349470981925
NCT01714037,A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC],0.0007910227763268301,0.0008116027173739864
NCT01786590,Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT),0.0006901269198195521,0.0005598626340327107
NCT01782287,Proteome-based Immunotherapy of Lung Cancer Brain Metastases,0.0006522399495180357,0.0004713266436677952
NCT01717482,Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer,0.0006339745183737889,0.0007507100110140815
NCT01745484,Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation,0.00047602483722107125,0.0006265892347623196
NCT02841228,Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer,0.0009786666850416497,0.0004994818599930313
NCT02895503,Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment,0.0007718506229960694,0.0008949966092551253
NCT02855281,Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer,0.0007292853240209577,0.0006410516946837232
NCT02877966,Evaluation of the Effects of a Mixture of Amino Acids (Amixea) on Lean Body Mass and Muscle Strengh of Patients With Unresectable Advanced Non-small Cell Lung Cancer,0.0007449840689092499,0.0007527397694061555
NCT02817945,Dual Integrin αvβ3 and SSTR2 Targeting PET Imaging in Lung Cancer Patients,0.0006444421874535949,0.0006230938938942218
NCT02844140,DE-CT in Lung Cancer Proton Therapy,0.0008997891787108265,0.00087561330490096
NCT02879617,A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients,0.0007757790283667194,0.0006642488944686703
NCT02875340,A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0008759499229893339,0.0009652725556526147
NCT02804776,PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery,0.0004829162068582961,0.000574466764676702
NCT02840227,The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections,0.0005668291293096847,0.0005496255778576584
NCT02840578,NK Cell Activity in Smokers Screened for Lung Cancer,0.0007366274281285466,0.00042440981849021424
NCT02802540,"Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients",0.0005848981162315518,0.0006143155748208954
NCT02894853,Lung Cancer Early Molecular Assessment Trial,0.0006449979294290251,0.0005994688482026693
NCT02888743,Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer,0.0007285982485091584,0.0007537321339396823
NCT02887521,Pulmonary Rehabilitation Before Lung Cancer Resection,0.0006439050678842112,0.0004623049348630795
NCT02869685,Clinical Research for the Consistency Analysis of PD-L1 in Lung Cancer Tissue and Plasma Exosome Before and After Radiotherapy,0.00047247020868261037,0.0005137111429961448
NCT02848872,Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer,0.0005865601789791503,0.0006131562503047089
NCT02803619,A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis,0.0007670274241763346,0.0007942559600896861
NCT02803333,Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study,0.0005570532254084153,0.0005597146836769821
NCT02803203,Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers,0.0005749954470809087,0.0006734752384333379
NCT02835690,"Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)",0.0007222256124691696,0.0010074084392400146
NCT02801409,Epidural Anesthesia/Analgesia and Outcome of Patients After Lung Cancer Surgery,0.0006484810393329947,0.0005929903877135201
NCT02801734,Enhancing Quality of Life in Patients (EQUIP) Intervention for Patients With Advanced Lung Cancer,0.0006486985267242498,0.0006337922628568683
NCT02846792,"Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer",0.0007479927037057164,0.0008407413968373766
NCT02846103,Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer,0.0006480980580140574,0.0006239240121174441
NCT02831959,Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS),0.0007317776641520164,0.000730247848490333
NCT02827357,Responses to Chemotherapy of Patients With Non-small Cell Lung Cancer Harboring a Known Somatic Activating HER2 Mutation,0.0008325162014930773,0.000633580030386841
NCT02827344,PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer,0.0007342321003870921,0.000646312751075162
NCT02898116,"A Study of ALK Inhibitor, Ensartinib, and Anti-PD-L1, Durvalumab, in Subjects With ALK-rearranged Non-small Cell Lung Cancer",0.0006602267667545033,0.0005989968645427984
NCT02839265,FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer,0.0006468765843467419,0.0006504656346898636
NCT02839629,Long-term Epidemiological Follow-up of Non-small Cell Lung Cancer in Scandinavia,0.0013112651325000633,0.0010032866521697283
NCT02897765,"A Personalized Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer",0.0005870940652276179,0.00070578203931282
NCT02821936,Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer,0.0006441423967242264,0.0006369633314375749
NCT02821949,Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy,0.0007246347469134649,0.0008003489042719492
NCT02845856,Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer,0.0006591373473843166,0.0009030956086348244
NCT02809456,"Mitigation of Radiation Pneumonitis, Fibrosis and Heart Toxicity With Nicorandil in Lung Cancer Patients",0.0005510390228843599,0.0006157155254053206
NCT02810457,Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer,0.0008048209519289103,0.0010720898730773463
NCT02810262,Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS),0.0005475091781249217,0.00047313869897004
NCT02873416,Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer,0.0007303296620476797,0.0005787538475150218
NCT02853006,Study on Fluids Associated to Lung Cancer,0.0007707278450067843,0.00047321146491219627
NCT02853188,Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung,0.00052659185402552,0.0005942025662892071
NCT02856581,Smoking Cessation Prior to Surgery to Reduce Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes,0.0005867093027583291,0.000550990700160603
NCT02822209,"Evaluation of the Impact of a Coordinating Nurse in a Personalized Care Program on Quality of Care, Coordination of the Actors and on Quality of Life for Patients With Lung Cancer",0.0005739668546302531,0.0005426184506054571
NCT02824458,A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations,0.0008315354750060684,0.0008105297312359771
NCT02823990,TG4010 and Nivolumab in Patients With Lung Cancer,0.0009103474070369338,0.000702106833423436
NCT03101579,Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer,0.0007397817820384295,0.0007187810821104628
NCT01574300,Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network,0.0005638083090516691,0.0006647028510096162
NCT01579188,Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer,0.0008194035827261195,0.0008539128984372833
NCT01579994,Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers,0.0005221188259394365,0.0005542911441276777
NCT01592617,Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer,0.0008293183945426451,0.0006957422022510233
NCT01580332,Non-Invasive Biomarkers For Early Detection Of Lung Cancers,0.0005366122372432175,0.0005016173359245435
NCT01580735,ARQ 197 Plus Erlotinib in Patient With Locally Advanced or Metastatic EGFR Mutation-positive Non-small-cell Lung Cancer,0.0006805707552504975,0.0007385469591605026
NCT01580982,Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer,0.0005238502919292311,0.0004497970960793999
NCT01580579,Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation,0.0006052641907148999,0.0004481736923414745
NCT01560104,A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.000839148905617426,0.0007419577665427486
NCT01560195,A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy,0.0008443860071003423,0.0007175826240581377
NCT01577212,Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy,0.0007274977082094018,0.0007455874352588637
NCT01551251,Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer,0.0007115134659348543,0.0008439475365884645
NCT01537991,ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial,0.0008103500328465091,0.0009318845666012364
NCT01515969,Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC),0.0006843586942777193,0.000719507769418806
NCT01585675,Specimen Banking From Patients With Lung Cancer,0.0009046133341004152,0.0005073316367197325
NCT01585883,Self-Management Intervention for Breathlessness in Lung Cancer,0.0005264710853169611,0.0006555282400291693
NCT01555502,Health Related Quality of Life After Video Assisted Thoracoscopic Lobectomy for Lung Cancer,0.00042608373612537036,0.00046978797792632926
NCT01507428,Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer,0.0007996899320209531,0.0007983837402190249
NCT01562015,A Study of Ganetespib in Subjects With ALK-Positive Non-Small-Cell Lung Cancer (NSCLC),0.0006864233663328966,0.0006717889964917845
NCT01578018,Tumor Markers in Lung Cancer: DCAMLK-1LK-1,0.0006727036873928659,0.0004628947790001549
NCT01546233,Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment,0.0006944294840183616,0.0007074709401898774
NCT01540552,Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer,0.0004696185229620958,0.0006008209622717249
NCT01529112,"A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments",0.0007192540806738333,0.0008258380501650904
NCT01565980,Mindfulness Therapy for Individuals With Lung Cancer,0.0006971374014891125,0.0006593873369692857
NCT01500876,A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer,0.0005263881634046378,0.0005369982012177644
NCT01527058,68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients,0.0007333058404914944,0.0005262799593752384
NCT01527461,Identifying Unique Scent Signature of Lung Cancer Through Body Odor,0.0006375299130371223,0.0005732399695305714
NCT01527864,Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer,0.0006677426645522552,0.0005875373173482226
NCT01576796,Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer,0.0006149699991725285,0.0006119114324601752
NCT01533233,Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer Patients,0.0005621776389853956,0.0006033503770018026
NCT01581346,Exercise Study in Patients With Lung Cancer,0.0008250150335253839,0.0006448655206477328
NCT01503385,Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0007859152891385428,0.0008079609918995359
NCT01539928,Dual PET/CT Imaging in Lung Cancer,0.0005370851890610078,0.0004202698629160409
NCT01532089,Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations,0.0007205166505563292,0.0008068071902846085
NCT01532362,Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer,0.0007173465764737613,0.0006510370297332632
NCT02237183,Iloprost in Preventing Lung Cancer in Former Smokers,0.0006442962762100827,0.0005287865254054707
NCT02202655,Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer,0.0007951920234534551,0.0009390767476443099
NCT02223611,Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection,0.0006116504077165395,0.0007965510445682036
NCT02299505,Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC),0.0007896318711009013,0.0007239875074910511
NCT02221739,Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC),0.0007018947113141045,0.0007834091370834379
NCT02274025,NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients,0.0007234600283185921,0.000452944021079765
NCT02271581,Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer,0.0005487760319553804,0.0004960562119164936
NCT02209727,Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer,0.0008457177296089884,0.000830871388162149
NCT02222194,The Value of Surgical Mediastinal Staging in Clinical N1 Lung Cancer,0.00048827793185731816,0.0005018824069571831
NCT02272127,Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer,0.000660715232422456,0.0006935467291038443
NCT02272413,Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer,0.0007568745706559033,0.00069250751664935
NCT02215356,Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer,0.0008014171365235503,0.0007533604228407947
NCT02204059,Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer,0.000809399104724774,0.0008488256716689538
NCT02204345,A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology,0.0007387479252462602,0.0006987851187798824
NCT02276027,"A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer",0.0008268737965335996,0.0009227932645194829
NCT02243748,Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers,0.0006925127063722407,0.0006615385197950193
NCT02206334,"Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer",0.0007367357578558832,0.0007290230360665943
NCT02262325,Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery,0.0007569161893091741,0.0009041172304334241
NCT02211833,Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer,0.0008348497112420165,0.0010055620783912186
NCT02297425,A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer,0.0008267118532108891,0.0005826937560705602
NCT02201992,Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial),0.000763515851054604,0.0008258336220530436
NCT02296125,AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007911801779219349,0.0006854419331862367
NCT02220894,Study of MK-3475 (Pembrolizumab) Versus Platinum-based Chemotherapy for Participants With PD-L1-positive Advanced or Metastatic Non-small Cell Lung Cancer (MK-3475-042/KEYNOTE-042),0.0007135007599550826,0.0008142278433013445
NCT02277457,"Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations",0.0006724462589360782,0.0006574824199731503
NCT02250326,"Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer",0.0007302755490551332,0.000836067768336653
NCT02250378,Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer,0.0007625595108463827,0.000760111910487553
NCT02245100,Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer,0.0007296174702894638,0.0008632902528476261
NCT02273336,Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer,0.0007308075558557441,0.0007810821538087781
NCT02208843,Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation,0.0007017389414731225,0.0006215991397648019
NCT02231164,LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research,0.0006537731743410107,0.0005551826288151399
NCT02292550,Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.,0.0008146162603821815,0.0008897123865927212
NCT02284633,Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer,0.0007229556904407324,0.0007029399305058914
NCT00590902,"Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer",0.000660480612888139,0.0007404773631629327
NCT00532155,A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer,0.0008270551989365366,0.0008292993124361213
NCT00570401,Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib,0.0006597738921264604,0.0006575507979373206
NCT00531076,Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer,0.0006673164954941851,0.0006805437017645109
NCT00516022,"Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.",0.0006936242987212045,0.0007957873469337562
NCT00563420,Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer,0.0005671957959667685,0.0005286754466240582
NCT00563160,Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery,0.0005441582268558118,0.0005518011824783354
NCT00517790,Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008156314284151062,0.0011383122064066483
NCT00540280,Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer,0.0005997100359027839,0.000742460008532232
NCT00545948,Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer,0.0005940242896893678,0.000898230940424884
NCT00547105,Erlotinib and Stereotactic Body Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Non-Small Call Lung Cancer,0.0006481699420660658,0.0005970009884106753
NCT00509457,GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC),0.000836325200831337,0.0005666242580147725
NCT00596310,"Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning",0.00043562076820787053,0.0005762484793448338
NCT00569114,Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients,0.0009016519405983926,0.0009710970841765147
NCT00569712,Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol,0.0005597255951306301,0.0004555844772495309
NCT00586937,Quality of Life in Lung Cancer Survivors,0.0009061974714285359,0.00047173258233005764
NCT00553254,Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer,0.0010122121607690356,0.0014469218462369795
NCT00559065,A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China,0.0005105185529520529,0.0005832537516607666
NCT00582348,Physical Activity and Inactivity in Lung Cancer Survivors,0.0006461786121049476,0.0006133862960893936
NCT00508144,Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer,0.0005867914880840796,0.0006107614672363556
NCT00556647,Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUS,0.0005412230201500538,0.000711888018683373
NCT00522938,Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007721705604269144,0.0008631880925614031
NCT00522639,Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation,0.0006141444550281411,0.0006556597637696637
NCT00522197,ACAPHA in Preventing Lung Cancer in Former Smokers With Bronchial Intraepithelial Neoplasia,0.0006439069191994727,0.0004866040271730991
NCT00578084,Lung Cancer Location: a Repository,0.0008986078023327957,0.00046116614079544154
NCT00519805,Dalteparin in Preventing Blood Clots in Patients With Lung Cancer,0.0007210853789403616,0.0005760225541614023
NCT00585377,"Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer",0.0006385019960860058,0.0006562533756552009
NCT00588835,Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients,0.000659796911579606,0.0007353338980881674
NCT00530621,Study of Enzastaurin Versus Placebo With Pemetrexed for Patients With Advanced or Metastatic Lung Cancer,0.0006977419701331568,0.000741989493015428
NCT00597636,Genetic Susceptibility to Lung Cancer in Never Smokers,0.0005281267465078278,0.0004623169848542482
NCT00506467,Vibration Response Imaging (VRI) in Lung Cancer Patients,0.0009034311467531367,0.000521305113202196
NCT00568282,Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients,0.0006330955967318064,0.0008430816674455868
NCT00568490,Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers,0.0005737230965936991,0.00058674959417977
NCT00579215,Lung Cancer Informational Study (LCIS),0.0006203459327054911,0.0005979632361569662
NCT00579462,Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer,0.0005419013986313954,0.0006488794190095885
NCT00579683,Registry for Patients With Acquired Resistance to Small Molecule Kinase Inhibitors in Non-Small-Cell Lung Cancer,0.0007053487448160244,0.0006212766735768499
NCT00512642,Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients,0.0005541561796401706,0.0006587843718488444
NCT00527982,Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer,0.0006304851103228502,0.0005365272972487902
NCT00504374,Gene Polymorphisms and Symptoms in Lung Cancer Patients,0.0009061341168593887,0.0006673633614409128
NCT00503958,Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer,0.0005780515904924309,0.0005682586287631969
NCT00583830,A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer,0.000671581316166036,0.000848650998314879
NCT00514215,Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer,0.0006298998951662808,0.0005932035972212139
NCT00538681,"Study for Patients With Advanced, Not Amenable to Surgery, or Metastatic Lung Cancer Comparing Treatment With Pemetrexed + Cisplatin + Enzastaurin Versus Pemetrexed + Cisplatin + Placebo",0.0007409910801504601,0.000756687397818414
NCT00576914,Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer,0.0007187606682301525,0.00071572381816408
NCT02786589,Plasmodium Immunotherapy for Lung Cancer,0.0006425655131672892,0.0006910464621559577
NCT02715102,Circulating Tumor DNA in Patients at High Risk for Lung Cancer,0.0007392688717793628,0.0005714812265908622
NCT02731001,Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer,0.00047943333564987836,0.0005498946620860792
NCT02710565,Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma,0.0005293079237521236,0.0003421899125831569
NCT02743923,Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer,0.0006541873140865471,0.0007545836513286394
NCT02734524,A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer,0.000646829685435149,0.0007755478880881662
NCT02713867,"A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks",0.0006374231192734963,0.0007366815424869084
NCT02701699,18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer,0.0008986078023327957,0.0007146503991291315
NCT02701231,Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer,0.0005380152743031665,0.0009388126673366097
NCT02740894,Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?,0.0005887436146594572,0.000653754926280281
NCT02754882,A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer,0.0008697425237822067,0.0008811059608870269
NCT02754388,Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography,0.0005252833916361448,0.000447998703051435
NCT02716051,Wholebody MRI In Lung Cancer StagiNg,0.0017169554734706223,0.0005047294087654896
NCT02716311,Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer,0.0006550097422916481,0.000726202430261114
NCT02736643,Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography,0.0006232990042021655,0.0004701770424257708
NCT02789345,A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer,0.0006221755941654432,0.0009253301927089045
NCT02758678,Analysis of P-Selectin Expression on Platelets of Blood From Lung Cancer Patients,0.0005869425585869846,0.0005237132224671878
NCT02732834,Doctor-Patient Communication in Lung Cancer Care,0.0012981398033125688,0.0007188057121988976
NCT02781857,Mass Spectral Fingerprinting in Lung Cancer,0.0008986078023327957,0.0005504179401178089
NCT02720614,Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer,0.0008288668109428738,0.0008728263063079705
NCT02730247,Clinical Trial of the Safety and Efficacy of the Addition of Ramucirumab to Nab-paclitaxel in Previously Treated Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007829457989183949,0.0007925923521960147
NCT02771470,Intestinal Microflora in Lung Cancer After Chemotherapy,0.0006804825834474939,0.0006136424038430832
NCT02771756,The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy,0.0006582587977684252,0.0007653917067232725
NCT02726633,Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer,0.0005463967600411269,0.0009329311100318104
NCT02705404,A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing,0.0004737243223961561,0.0004270742593382621
NCT02705339,Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC),0.0007675376703160915,0.00059278402975713
NCT02780778,Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,0.0007841760125286754,0.0008821605556292127
NCT02733107,The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer,0.0007029484033404109,0.0005903354242791423
NCT02708667,An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer Patients,0.0007055655636536509,0.0006726673166136069
NCT02777788,Curative Study of Chinese Traditional Medicine to Treat Lung Cancer,0.0007722917903310755,0.0009002546606334682
NCT02773238,FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging,0.0007460916244042061,0.0008185422934193083
NCT02737774,Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation,0.0008429674697855319,0.0010534481428148904
NCT02770014,Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer,0.00047877692136355103,0.0006849406900412168
NCT02718651,Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer,0.0006345890736217019,0.0007814476633178808
NCT02793856,PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung Cancer,0.0007596480368783064,0.0009874414429502654
NCT02764606,CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer,0.0007411041707777646,0.0006800835659357954
NCT02764866,Sleep Apnea in Lung Cancer: A Prospective Study,0.000769942345444894,0.0008080423850727945
NCT02764086,INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer,0.0010973335861418593,0.0006394629575503748
NCT02755454,Perfusion CT Imaging in Lung Cancer With SBRT,0.0006467856985358773,0.0006225286214900022
NCT02755675,"uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung",0.0007134989519815829,0.0007226485790712092
NCT02755337,The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase,0.0006434514338819942,0.0006974241453790676
NCT02755883,Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients,0.0006350594417563992,0.0005080226569160466
NCT02775435,A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407),0.0006793805563379524,0.0007740795870434249
NCT02759679,Canine-Assisted Profiling of Lung Cancer From Human Breath,0.0006399321320306609,0.0005599928405317705
NCT02738593,Detection Cell Free DNA in Lung Cancer Patients,0.0009367401666942132,0.0006085396974762578
NCT02738684,A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test,0.0005532542268577545,0.0005668107358612479
NCT02745002,Navigated EBUS and Functional Imaging in Lung Cancer,0.0008986078023327957,0.00042169197330727486
NCT03070626,Preoperative Loading With Carbohydrates in Lung Cancer Surgery,0.0006684829362908929,0.0005151262847822851
NCT03091491,Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer,0.0006814032748717962,0.0006877018645690854
NCT03091816,"Dynamic Perfusion Computed Tomography Changes Before, During, and After Stereotactic Body Radiation Therapy in Patients With Localized Non-small Cell Lung Cancer",0.0007071689361799162,0.000715363495892904
NCT03014648,Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC),0.0007319425498887858,0.0005148667247552889
NCT03084692,Therapeutic Yoga and Resistance Exercise for Lung Cancer,0.0005034844847368192,0.0005178359533620454
NCT03089125,Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer,0.0006976322927124456,0.0009541839413329585
NCT03077854,Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial,0.00044728094370136324,0.0005134013187372605
NCT03092739,A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens,0.0005484014146512481,0.0007794536347498522
NCT03092986,Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer,0.000677018722655146,0.0006636560963030102
NCT03087708,Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.000832324468202282,0.0007900915870312867
NCT03048500,Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery,0.0007174261679261553,0.0007965578926146438
NCT03048136,A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer,0.0007055432564375423,0.0007814963264861703
NCT03048760,Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients,0.00062957643061833,0.0006662738039688558
NCT03053804,"Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction",0.0006040121942897626,0.0007329881140842976
NCT03053856,Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients,0.0008103839883933847,0.0009326893116519439
NCT03006575,Study of Consolidation Chemotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection,0.0006501912017804411,0.0007170802836754661
NCT03007953,Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II,0.0005307723945908735,0.0005376184951210315
NCT03007875,High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer,0.0005948276534843724,0.0008288670553242339
NCT03088930,Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer,0.0007389653885079625,0.000780185458402792
NCT03081741,Circulating Tumor DNA in Surgical Lung Cancer Patients,0.0007598520572425515,0.0011790205896428719
NCT03029871,Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer,0.0005185693683403644,0.0005954263821636801
NCT03029325,Molecular and Genetic Analysis of Lung Cancer,0.0006394692300833675,0.0005858236087405427
NCT03054038,Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer,0.0007647953171275141,0.0007999481614345695
NCT03017885,Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy,0.000758601294787854,0.0005695588562934657
NCT03017183,Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy,0.00043654188328259256,0.0005597716197999853
NCT03095612,Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC),0.0006760120482862308,0.0007942076854356113
NCT03068663,Microbiota and the Lung Cancer,0.0017169554734706223,0.0006311147792616859
NCT03003468,Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017,0.0005943920144816236,0.000588426507763156
NCT03003962,A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer,0.0007196405631859377,0.0007036550820939943
NCT03010033,Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer,0.0007291679096060634,0.0005614214145999097
NCT03010657,Evaluation of a Food Intake Modification for Lung Cancer Patients,0.0006400267116477445,0.0009238255167570516
NCT03086733,Phase II Lung Metcore - Preoperative Metformin for Lung Cancer,0.0006449462206308769,0.0004842314964763373
NCT03047616,A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer,0.0005647791323600737,0.0006851785992013763
NCT03057340,The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells,0.0006464727762670568,0.000581409189374406
NCT03090737,Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer,0.0007409399530198791,0.0010320102517093167
NCT03090880,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE),0.0005287349604616476,0.0004517294611286817
NCT03030131,Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer,0.000661501329664489,0.0007640732823277793
NCT03073902,The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.,0.0005927674976370755,0.0005950177757541224
NCT03083691,BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer,0.00047587715840687625,0.0006164775258672461
NCT03099577,PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer,0.0006017942514086678,0.000763233223434494
NCT03009630,ENB Guided RFA for Early-stage Peripheral Lung Cancer,0.0006912718301380494,0.0007543594050362436
NCT03020251,Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer,0.0007256430071899076,0.0005583459671391119
NCT03082300,A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations,0.0007515285688241395,0.0007446487974523429
NCT03065764,89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer,0.0009096007179377445,0.0004693437983508932
NCT00256789,Once Weekly Radiation for Lung Cancer With Chemotherapy,0.0007340324669108615,0.0008929361061927447
NCT00255489,A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer,0.0006882779576996835,0.0008027558476367101
NCT00255775,Broccoli Sprout Extract in Preventing Lung Cancer in Smokers,0.0005241425481822596,0.0003622709999850141
NCT00243867,Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer,0.0005820131195940997,0.000640326045647076
NCT00250848,Lung Cancer Case Registry and Tissue Resource,0.0005269457978878962,0.000522915218452496
NCT00219297,Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer,0.0008149349735264648,0.0008589010216016224
NCT00251589,A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025),0.0007191050363607547,0.000762668598131484
NCT00265200,Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer,0.0004724953688044277,0.0006587085764674425
NCT00264602,Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer,0.0005217701328170218,0.0005316974209686009
NCT00281125,Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer,0.0006727097032556538,0.0005704604647014178
NCT00221169,Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer,0.000506388038197456,0.000676019043672886
NCT00280202,Detection of Genetic Markers of Lung Cancer,0.0005409894180717417,0.0004164088722213964
NCT00214123,Hypofractionated Radiotherapy for Lung Cancer,0.000900370294183814,0.0004562112718713084
NCT00263731,Metabolomic Analysis of Lung Cancer,0.0017169554734706223,0.001152789421355322
NCT00218179,Assessing the Link Between Smoke Carcinogen Biomarkers and Lung Cancer Risk - 1,0.0005328190158066163,0.0005092781389367133
NCT00260871,Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications,0.0005543192626133327,0.0004814750232025356
NCT00260598,LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer,0.0007282818148928344,0.0007141656595309492
NCT00294190,Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer,0.0007964330960781277,0.0007117257520428393
NCT00294736,A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy Regimens,0.000777265372188867,0.0007668406578612024
NCT00246727,Effects of Selected Vegetable and Herb Mix (SV) on Advanced Non-small Cell Lung Cancer,0.0010215111084779785,0.0007524882758291409
NCT00277329,Study of XL999 in Patients With Non-small Cell Lung Cancer,0.0010321614941224677,0.0007787071054330602
NCT00210080,A Study to Diagnose Lung Cancer by Sputum Cytology (01-312),0.0006313872019872411,0.0006032718491976041
NCT00273494,Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2,0.0006516983630845426,0.0008567099989198943
NCT00268970,Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0008061282048648277,0.0009761599367991075
NCT00290550,A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006),0.0010366588483814842,0.0011186492334307368
NCT00290355,Study to Test the Efficacy of the Vaccine GSK 249553 in Treating Non-small-cell Lung Cancer After Tumour Removal by Surgery,0.0005212260060864242,0.000756271465937522
NCT00226577,Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.,0.0006721185521397675,0.0007313310190463148
NCT00238602,Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer,0.00047458231335366873,0.000525502715017496
NCT00238875,A Phase II Study of Stereotactic Body Radiation Therapy in Patients With T1N0M0 Non-small Cell Lung Cancer (JCOG0403),0.0008873217968790087,0.001239690628483514
NCT00266812,Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED),0.0007774333988552746,0.0007721644608013053
NCT00270582,A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer,0.0007233452818316847,0.000816884378626683
NCT00257179,The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor,0.000588873730785083,0.0005462891876274097
NCT00213733,Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer,0.0007188697952759801,0.0006657402229802798
NCT02366143,A Phase III Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination With Carboplatin + Paclitaxel With or Without Bevacizumab in Patients With Stage IV Non-squamous Non-small Cell Lung Cancer [IMpower 150],0.0007972070688098941,0.0008765100981985503
NCT02397239,Comparison of Cost-effectiveness of Continuation Maintenance Therapy With Six Cycles of Pemetrexed Versus Pemetrexed Until Disease Progression for Metastatic Non-squamous Non-small-cell Lung Cancer,0.0004489921606067067,0.0007893908412205855
NCT02373917,Characterization of Methylation Patterns in Lung Cancer,0.0017169554734706223,0.0007209424876691665
NCT02380196,The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer,0.0007377052371456345,0.0008283478648852375
NCT02335944,Study of Safety and Efficacy of EGF816 in Combination With INC280 in Non-small Cell Lung Cancer Patients With EGFR Mutation.,0.0009069658653495434,0.0009296091203438864
NCT02312622,Phase II Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer,0.0005337789934185453,0.000693833547520112
NCT02332512,Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR),0.0008372276624433621,0.0008366092381264147
NCT02363101,Health Outcomes and Costs (HOC) in Lung Cancer (LC),0.0008986078023327957,0.0006436466563411888
NCT02317016,"Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer",0.0007742570908243607,0.0007831644051103025
NCT02336061,Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer,0.0008029569011959158,0.001046826551439514
NCT02350361,Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.,0.0004922402590193931,0.0005060038740725768
NCT02362204,Lung Cancer Nurse Model: a Phase II Study,0.000769942345444894,0.0005707208355061463
NCT02300298,Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy,0.0007216089103047468,0.0006808388962427114
NCT02308865,Early Palliative Care in Metastatic Lung Cancer in Northern France,0.0005480796582627519,0.00037628185626422295
NCT02308020,"A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain",0.000634763656603965,0.0007490811913104012
NCT02381808,Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China,0.0006752965543674706,0.0006409123283454969
NCT02388074,Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer,0.0004663418276152541,0.0005010334966502521
NCT02309567,"Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?",0.000562171030868438,0.0007574750408485483
NCT02385812,Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma,0.0005227971049253736,0.0005040695886148305
NCT02392728,Virtual Environments in Patients Receiving Treatment for Lung Cancer,0.0009634736008335548,0.0005672345941480616
NCT02320617,Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer,0.0005342375694586997,0.0005826932838669
NCT02315053,PET Response During Chemoradiation of Lung Cancer,0.0005400529611931582,0.0006492530629901678
NCT02372448,Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients,0.000558393878114992,0.0008884177673897352
NCT02358473,Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer,0.0007286648879447241,0.0008734773140749635
NCT02318771,"Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer",0.0006066642883913358,0.0006650786867058911
NCT02318368,"A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label",0.0006730956352038693,0.0007072288988357035
NCT02323126,Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer,0.0008310565777443077,0.0009540203811488487
NCT02364804,A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung Cancer,0.0006464659888395165,0.000755677858231537
NCT02364609,Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib,0.0007223954654847459,0.0007834003606997286
NCT02394548,Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer,0.0007458842467850519,0.0005070918566772121
NCT02342353,Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI),0.0007270670935570605,0.0007652475388816042
NCT02337712,Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer,0.0005613150895237786,0.0007208461416428385
NCT02331290,Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen,0.000721677433412143,0.0006758841248026801
NCT02348450,Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer,0.0005075050980794795,0.0006044363602990548
NCT02354274,Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®,0.0005613240716199179,0.0004451268765105326
NCT02301858,Identification of Predictive and Prognostic Markers for Lung Cancer With Metastases,0.00047797538732441945,0.0004529792125886222
NCT02367794,A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Participants With Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) [IMpower 131],0.0006809108051727328,0.0007793170999469989
NCT02393209,Docetaxel With or Without MLN1117 in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0007342275817071935,0.0008533830404932872
NCT02393625,Study of Safety and Efficacy of Ceritinib in Combination With Nivolumab in Patients With ALK-positive Non-small Cell Lung Cancer,0.0007783832839830462,0.000803220182843281
NCT02357992,Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy,0.0007353204044342452,0.000782191152492054
NCT02357836,Neoadjuvant Itraconazole in Non-small Cell Lung Cancer,0.0007310147699703524,0.0009372744363554906
NCT01396551,Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy,0.0006619809073993022,0.0006543484924689101
NCT01351415,A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),0.000738844527035239,0.000704946342302412
NCT01351116,A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy,0.0006742712794718555,0.0006983601450570069
NCT01312337,Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC),0.0006656467474129012,0.000539769830826706
NCT01336634,Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.,0.0006540987639264679,0.0007022639269435545
NCT01336543,Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC),0.0006209305413948617,0.000788076013423723
NCT01336192,Maintenance Gemcitabine in the Chinese Advanced Lung Cancer,0.0007551450523555905,0.0007164405723303641
NCT01385111,Combined Application of EBUS and EUS in Lung Cancer,0.0009009923897143701,0.0004812004950839709
NCT01383408,Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection,0.0005311550397985092,0.0005194663379308628
NCT01358942,An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab),0.0006246192915819091,0.0006734484803652301
NCT01399541,Recovery and Rehabilitation After Lung Cancer Surgery,0.0005434338908293702,0.00046266809692341847
NCT01325753,Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body,0.0005883639412147898,0.0006717850492437659
NCT01360931,The Roles of Neutrophil Elastase in Lung Cancer,0.0008986078023327957,0.000601731014921064
NCT01389739,Intervention to Improve Continuity of Care in Lung Cancer Patients,0.0006344658002046195,0.000634715934793595
NCT01356303,Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer,0.0007420448740487661,0.0007699582948863922
NCT01302626,Radiomics: a Study of Outcome in Lung Cancer,0.0010973335861418593,0.0005348954708540653
NCT01386203,Exhaled Breath Biomarkers in Lung Cancer,0.0006566643916461461,0.0006624493792662389
NCT01386385,"Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007546852282627413,0.0008789084573075537
NCT01359436,e- Ab Sensor-based Real-time Detection of Mutant EGFR in Clinical Specimens From Patients of Non-small Cell Lung Cancer,0.000711602829728146,0.0007283730013262992
NCT01310387,Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM),0.0006203437738675758,0.0005113903221461128
NCT01310244,Maximum Tolerated Dose Study of Belinostat (PXD-101)in Combination With Paclitaxel Plus Carboplatin in Chemotherapy-Naive Patients With Stage IV Non-Small-Cell Lung Cancer (NSCLC),0.0008325505687895872,0.0007616508641960151
NCT01337037,Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC),0.0006022424802922014,0.0008364887686857397
NCT01391260,Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0007963270548584921,0.000887453323800251
NCT01342965,A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations,0.0008023282928989324,0.0007904215492418318
NCT01342770,Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer,0.000832324468202282,0.000974336899156214
NCT01305967,Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer,0.0007839036047369754,0.0009469925701850261
NCT01306188,Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients,0.0005660796643480603,0.0005840421896471359
NCT01300299,STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO),0.0007340324669108615,0.0006885297657970857
NCT01300429,Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus,0.0005569444270178958,0.0005637757394008228
NCT01362842,Psychological and Physical Distress and Care Needs in Operable Lung Cancer Patients Receiving Surgery,0.000603224275644372,0.0006134777715111172
NCT01362296,An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer,0.0006791524045777744,0.0008165513448591526
NCT01309087,Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA,0.0004707167783628359,0.0005361205071373758
NCT01363557,Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis,0.0006711726775712887,0.0006377812198017586
NCT01313663,A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population,0.0006896671758566484,0.000674656161547972
NCT01394679,A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer,0.0005557652620441771,0.0005317230826075817
NCT00887783,Navelbine And Radiotherapy in Locally Advanced Lung Cancer,0.0006414801554759795,0.0007053951736487423
NCT00880971,To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer,0.0008458780438589528,0.0006861765081951787
NCT00871403,Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer,0.0007267928481327389,0.0009589365570641243
NCT00856427,Implantation of Markers for the Radiotherapy of Lung Cancer Patients,0.0006739496126217472,0.0006268599641906861
NCT00898209,Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE),0.0004640343497143181,0.0004913125923373305
NCT00898313,Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer,0.0006384920984500152,0.000592828625746014
NCT00884598,Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer,0.0006196603303395409,0.0005212664151943212
NCT00807170,Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases,0.0007382437149174744,0.0007399288972150909
NCT00807391,Transbronchial Catheter Aspiration and Transbronchial Needle Aspiration in the Diagnosis of Lung Cancer,0.0004704762943276152,0.0005660114898950222
NCT00831545,"Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)",0.0006356002846044374,0.000706263792050985
NCT00867412,Randomized Study of Positron Emission Tomography - Computed Tomography (PET/CT) in Pre-Operative Staging of Lung Cancer,0.0005586872507000173,0.0006818593068608803
NCT00818402,Non-small Cell Lung Cancer and Quality of Life,0.0009179799713981616,0.0008067081365518405
NCT00886678,A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801),0.0008688643949976923,0.0008589303674570774
NCT00830245,A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer,0.000678221763845517,0.0008185013322596959
NCT00866528,Study of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung Cancer,0.0007316498728681702,0.0007423429040303795
NCT00894127,Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer,0.0004663418276152541,0.0004815381880489678
NCT00852462,Lung Cancer Symptom Assessment and Management Intervention,0.0005257010220963274,0.0005409506159148355
NCT00870532,Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer,0.0008249365900600632,0.0007360831367260398
NCT00870870,A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Patients With Lung Cancer Who Have Not Received Chemotherapy Before,0.0006564331643263059,0.000868935301693175
NCT00832819,E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007676316796027586,0.0008724974664334477
NCT00862173,Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer,0.0006581697263066115,0.0008446332125794795
NCT00874588,Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer,0.0006918717475851599,0.0007097822792409807
NCT00855894,A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer,0.0007851701816217103,0.0008235048043222454
NCT00897143,Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer,0.0007263089171751053,0.0006053166944383692
NCT00897650,Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer,0.0006229167007307317,0.0006922168359629959
NCT00826852,Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax,0.0006609302595970184,0.0007121477850757083
NCT00826683,Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC),0.00061905056491022,0.0005830208861949451
NCT00826033,Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer,0.0005128239438387988,0.0005490056483403239
NCT00865319,Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007790998703750802,0.0006875537869857485
NCT00888511,Tarceva And Radiotherapy in Locally Advanced Lung Cancer Non-small Cell Lung Cancer,0.0007372763677137908,0.0007438825540210004
NCT00836992,"Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer",0.0006154011172182434,0.0006073192377244517
NCT00858403,Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation,0.0006575669525770125,0.000849240124465882
NCT00858520,"Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer",0.0004695825156924536,0.0004373959074689243
NCT00820755,Trial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC),0.0006000933366832976,0.0007279825516883086
NCT00806286,Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer,0.0006800145920062966,0.0007029291155553845
NCT00809237,Hydroxychloroquine and Gefitinib to Treat Lung Cancer,0.000644443301874992,0.0005497837123806918
NCT00883675,Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer,0.0005852962165014679,0.0007888733374416348
NCT00829322,Modafinil for the Treatment of Fatigue in Lung Cancer V9.0,0.000565148855368951,0.0005583712113595344
NCT00876460,"BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I",0.0008186171614707523,0.000746443503370036
NCT00899457,Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants,0.0005386601372074966,0.0003616334221767584
NCT00899262,"Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers",0.0006475205131520731,0.0006110827054925152
NCT00899028,Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants,0.0007405844833774609,0.0006201560323395154
NCT00899782,Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer,0.0006070207924253855,0.0006010017673066215
NCT00899405,Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer,0.0006020561931879731,0.0004980487722270039
NCT00840749,Randomized Study to Compare CyberKnife to Surgical Resection In Stage I Non-small Cell Lung Cancer,0.0006623041526133937,0.0006594064055689345
NCT00851448,"Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients",0.0006294286652737204,0.00036562219537973975
NCT00819728,Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer,0.0007576686860717023,0.0007588090182561708
NCT00864110,Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007804260896496304,0.0006492883317255438
NCT01642004,Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017),0.0007235553263844996,0.0008014215514078431
NCT01642251,Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer,0.0007328023814762999,0.000843087337277005
NCT01687439,Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC),0.0006330104611617214,0.0006213341351824237
NCT01687738,Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention,0.0005492137390000912,0.0007873195507920074
NCT01673711,Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer,0.0005276527310101818,0.0005182833116071149
NCT01620190,Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer,0.0007506922610751617,0.0007314806531057523
NCT01620853,Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test),0.0005923229971764577,0.0006760846100408411
NCT01684696,Virtual Intervention for Lung Cancer,0.0009097765369853774,0.00046221472483471353
NCT01647867,Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers,0.0006609136900946311,0.0005859146533928378
NCT01647425,Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer,0.0006296731045153236,0.0008073797175700697
NCT01647711,"A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations",0.0006254355127466049,0.0006799686454018237
NCT01656460,Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer,0.0004549956646374286,0.0006372303922797044
NCT01610544,18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma,0.0005080202851655885,0.0006688434171775804
NCT01688713,Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer,0.0009224190189433143,0.0007169181557171707
NCT01622621,Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer,0.0006359500951298909,0.0007005120701173333
NCT01668823,Photodynamic Therapy in Treating Patients With Lung Cancer,0.0009051501350370867,0.0006047858139211544
NCT01664533,An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy,0.0008647004767990638,0.000871799145746438
NCT01631357,Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer,0.0006586237954692166,0.0006624201358555772
NCT01631526,Vitamin D Loading Dose in Advanced Lung Cancer,0.0007462852362771111,0.0003745108837978029
NCT01685346,Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study,0.0007174133836585177,0.0006552740622140951
NCT01685138,LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer,0.0009336349111360041,0.0008219717956275658
NCT01660087,Diagnosis of Lung Cancer From Exhaled Breath With Silicon Biophotonic Device,0.0005315970206864894,0.00035074670828598247
NCT01661790,Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer,0.0006084059032708939,0.0007241345757266306
NCT01682850,Pulmonary Rehabilitation Before Lung Cancer Resection,0.0006439050678842112,0.0005619592093720446
NCT01648517,Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy,0.0006576825797589886,0.0006997559358399651
NCT01648166,A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens,0.0005473038674147239,0.0004461058104268744
NCT01649947,Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II,0.0010126078553165782,0.0007525701748248021
NCT01670539,Home Telemonitoring for Patients With Lung Cancer,0.0009034311467531364,0.0004975405908371685
NCT01617980,Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer,0.0004677427209028366,0.0008124332344688089
NCT01637376,Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer,0.0006368561779393936,0.0007145796908488693
NCT01658332,Circulating Tumor Cells in Lung Cancer,0.0009032417088488564,0.0006733981281576645
NCT01658813,"5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer",0.0004403192862120132,0.0005995403900215221
NCT01624051,A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer,0.0006888631322698301,0.0006545253147655719
NCT01652820,Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer,0.0006653013940332299,0.0006916353049927256
NCT01652469,Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.,0.0005835916367980654,0.0005071664735207525
NCT01679743,GRN1005 for Brain Metastases From Breast or Lung Cancer,0.0006491285337344069,0.0006368483168715458
NCT01619241,Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer,0.0006727574238763437,0.0007531239834469018
NCT01619501,Dysregulation of the C/EBPa Pathway in Human Lung Cancer and Search for New Biomarkers and/or Therapeutic Targets,0.0005778135966110258,0.0005159271915459529
NCT01037998,UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer,0.0005203146944743451,0.0004704418207595707
NCT01012401,Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer,0.000910316226027192,0.0005771734463208935
NCT01052818,Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer,0.0006204897937988877,0.0008136609010581142
NCT01082549,Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC),0.0005975100454298784,0.0005526656966646624
NCT01078883,Respiratory Muscle Performance and Functional Capacity in Primary Stage IIIb and IV Lung Cancer,0.0005602319422620157,0.0005121091902130611
NCT01039311,Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer,0.0005308179088560348,0.00046203108952478565
NCT01069575,Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Non-small Cell Lung Cancer,0.000719028853877169,0.000697317624338037
NCT01069640,Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cancer,0.000719028853877169,0.000697317624338037
NCT01069328,"Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)",0.0006920077570402822,0.0008065123521952926
NCT01058902,The Effect Of Aspirin On Survival in Lung Cancer,0.0008986078023327957,0.0003749823317688556
NCT01058811,Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue,0.0006094535473349887,0.0005446160896433384
NCT01090830,Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer,0.0006124341710446461,0.0006343999718972326
NCT01018147,4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition,0.0007633805348324552,0.0007256329138620871
NCT01046383,"Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients",0.000736863300088215,0.0007592813149141721
NCT01086254,SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer,0.0007561586617036009,0.0007241568962754741
NCT01003522,Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer,0.0006964562424393653,0.0005172943076215378
NCT01003964,Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV,0.0006167504497207595,0.000695264047336354
NCT01057212,Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006644148734426044,0.0006033030738360405
NCT01054482,Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer,0.0007271662496779796,0.0006462068994096651
NCT01040780,Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients,0.0009170591418301333,0.0011355437057833442
NCT01068210,Lung Cancer Exercise Training Study,0.0006242441617214334,0.00047095157834920885
NCT01014130,Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC),0.0006276784137013147,0.0007909163042986349
NCT01014286,Lung Cancer Mutation Consortium Protocol,0.0008986078023327957,0.0005627038755815531
NCT01014598,Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung Metastasis,0.0007417962946745968,0.0008510844112279059
NCT01006226,"64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab",0.000600757077074918,0.0006665948110425623
NCT01091376,Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC),0.0008058128966681934,0.0008889909225032321
NCT01064050,Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers,0.00043453055425231936,0.0006231641681989489
NCT01041833,Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker,0.0008156340951193577,0.0009629801084030736
NCT01051362,Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer,0.0007702158880078723,0.0007994448210445664
NCT01065415,Whole-Body Magnetic Resonance Imaging/Positron Emission Tomography (MRI/PET) in the Staging of Non-Small-Cell Lung Cancer (NSCLC),0.0006213547810417443,0.0007824996142304185
NCT01026844,Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC),0.0006845186712850579,0.0008066775323323786
NCT01027598,"Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer",0.0007500689794199205,0.0007856183863392633
NCT01067794,Chemotherapy in Treating Patients With Lung Cancer,0.0009471937149555912,0.0007724377984326987
NCT01085136,LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib,0.000733094486326158,0.0007509908879988281
NCT01038271,Integrated Versus Standard Palliative Care in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0007844888026630527,0.0008041237433902401
NCT01038752,Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer,0.0005936619398362537,0.0007736584958902185
NCT01000428,The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer,0.0006430788737775305,0.0007607668539184134
NCT01028729,A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC),0.0007173839217390954,0.0007849276829061609
NCT01048970,Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer,0.0005987281283776492,0.0005890161142978662
NCT01048645,Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer,0.0007756370777498413,0.0008470502926869382
NCT01088620,Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer,0.0007507993492336285,0.0006953624980495195
NCT01022671,Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy,0.0007998399280563998,0.0008373344614386413
NCT01025284,A Study for Patients With Small-Cell Lung Cancer,0.0010321614941224677,0.001378025111508652
NCT01005797,"Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers",0.0005098308950624496,0.000540855872009076
NCT01011595,"Minimally Invasive, Diagnosis and Staging of Lung Cancer",0.0006517510372628005,0.0005341531058312504
NCT01060137,Fentanyl Matrix in Lung Cancer Pain,0.0005194907754689256,0.0005682337437116716
NCT01079520,Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC),0.0005758108103992584,0.0006752084298953381
NCT01015443,"Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population",0.0006667171660597539,0.0007372081213116409
NCT01004601,Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer,0.0006635468689086223,0.0007683962016661152
NCT02445183,COPDGene/Lung Cancer Center Database,0.0006375129626099776,0.0004860982088625397
NCT02445872,Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy,0.0006168301086776526,0.0005486605303425805
NCT02459002,"Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project",0.0006733085022151852,0.0006421164075007393
NCT02416570,Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?,0.0005648267961224666,0.000798105111665686
NCT02416739,Anticancer Activity of Nicotinamide on Lung Cancer,0.0006406498390965499,0.0005838853194219741
NCT02496663,EGFR Inhibitor AZD9291 and Necitumumab in Treating Patients With EGFR-Positive Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor,0.0007163312049454267,0.0008036161887219786
NCT02404675,High Dose Icotinib in Advanced Non-small Cell Lung Cancer With EGFR 21 Exon Mutation,0.0008144705068472146,0.0009303856093699802
NCT02481830,Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer,0.0006586770854308291,0.0009228289894860141
NCT02481726,68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT,0.0005304924681863259,0.0003915328121894604
NCT02425748,Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation),0.0013112651325000633,0.0009670299989040924
NCT02400814,MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer,0.000836327011045758,0.0006945922831079631
NCT02410369,Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer,0.0006338968736974846,0.0007282136023054
NCT02410603,Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer,0.000524575812644205,0.0007264906992079542
NCT02410382,Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer,0.0006040494280118322,0.0007143410888955779
NCT02488928,E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung Cancer,0.0006375291840933743,0.00045326542916073067
NCT02488694,Maintaining ERBB Blockade in EGFR-mutated Lung Cancer,0.0008986078023327957,0.0006411022393143853
NCT02417662,Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer,0.0007708455993158276,0.0007378325056633187
NCT02437760,The Prognostic and Predictive Value of the CA-125 Marker in Lung Cancer Monitoring,0.0004771717120236509,0.0005285336798139964
NCT02423590,Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers,0.0007084026842405427,0.0007884288058456727
NCT02423148,Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer,0.0005448136445535015,0.0004798541940920273
NCT02407366,Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer,0.0007703242552759221,0.0006574084950014896
NCT02407912,Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer,0.0007374550995913671,0.0005619889088093351
NCT02452463,Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy,0.0007335519477691712,0.000759013260268484
NCT02470468,Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer,0.0006668768132400842,0.0007663055106662567
NCT02412384,The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment,0.0006236658814771408,0.00048226104408222956
NCT02414672,CareSTEPS: A Supportive Care Program for the Caregivers of Advanced Lung Cancer Patients,0.0006990295209104761,0.00044950825366378057
NCT02414139,Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer,0.0008309912672871737,0.0008369630907596748
NCT02462356,Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung Cancer,0.000636501934422679,0.0009244431985080269
NCT02499614,Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS),0.0006780386052455575,0.000541752811254048
NCT02480634,Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer,0.0006667839889653881,0.0006569683705175918
NCT02486718,Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010],0.0006829691958645274,0.0007730887358333741
NCT02484872,Has Inflammation a Significant Implication in Lung Cancer Evolution?,0.0006375440085222058,0.0004970956888690169
NCT02495233,A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acquired Resistance to an EGFR Tyrosine Kinase Inhibitor (TKI),0.0007201748465477695,0.0007031787567981887
NCT02493114,Functional Status in Patients Undergoing Curative Treatment for Lung Cancer,0.000767064584222201,0.0006677556182865663
NCT02450539,A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer,0.0007285607238570375,0.000828615113303475
NCT02448303,Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer,0.0006365151313837956,0.0007127447242891061
NCT02448758,Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²),0.0013112651325000633,0.00037737605335348
NCT02448992,Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer,0.0006382747990096164,0.0008517899102668408
NCT02448225,18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules,0.0005818433774296882,0.00043933763721572554
NCT02448797,Icotinib Versus Vinorelbine/Platinum as Adjuvant Therapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation,0.0005900621149938151,0.0007662346976996269
NCT02403193,Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008996961567682441,0.0007216410736500199
NCT02438722,"S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer",0.0007097441750963135,0.0007680807164660206
NCT02490696,Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer,0.0007111950055958661,0.00081038390199252
NCT02453282,Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC).,0.0006453619027002263,0.0006668356744620683
NCT02421718,Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation,0.0006196755674288095,0.0005783402484850074
NCT02426658,Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3,0.0007435273030175325,0.000804968058873287
NCT02408016,Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma,0.0007473582398996353,0.0008302615961222142
NCT02451865,"Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer",0.0007538415265901314,0.0008424270086657691
NCT02497586,Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer,0.0008986078023327957,0.0003943053436910586
NCT02443337,A Study of LY3023414 and Necitumumab in Squamous Lung Cancer,0.0007714956684629318,0.0008425820784881498
NCT02420314,Pharmacological Ascorbate for Lung Cancer,0.0008986078023327957,0.0006175598160303496
NCT02409108,Perfusion-Induced Hyperthermia in Lung Cancer,0.0006386921109355862,0.0005188145364450758
NCT02468024,JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer,0.0005652687345203524,0.0005088481920919079
NCT02468661,"A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification",0.0008638738123518453,0.0008061743384346503
NCT00101920,ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006711010003741286,0.0006129171135518017
NCT00190710,A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer,0.0007558214062262262,0.0007459417090394163
NCT00184964,Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis,0.0007111236451683707,0.0007252565251820559
NCT00179686,A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer,0.0006429264402176436,0.0006761680740353176
NCT00185913,Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers,0.0005859031125240703,0.0007460604727509378
NCT00119613,A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa,0.0006621851806715958,0.0007308004174555287
NCT00119470,EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer,0.0007359839299566725,0.0005422312349795578
NCT00124280,Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008514052654535163,0.0008150079723859927
NCT00173524,PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC),0.0006497652371823155,0.0007905846197589725
NCT00173680,Methylation Status of CD44 Promoter Region in Primary Lung Cancer,0.0009003271912526783,0.0007221130055117997
NCT00125359,Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer,0.0006890937090785375,0.0007010952547516265
NCT00125372,Study of Tarceva and Targretin in Stage I-II Lung Cancer,0.000581420656724383,0.000642020114856162
NCT00171834,"Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer",0.0008852705122865242,0.0009885671472608965
NCT00160069,Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer,0.0006552876433348512,0.0009150191642432669
NCT00111839,Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer,0.0005513196092481945,0.0006979869039017149
NCT00193921,Chemoradiotherapy in Patients With Localised Lung Cancer,0.0009061213237286979,0.0006623270573408487
NCT00103116,"Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer",0.0007390327225646615,0.0006753959643551944
NCT00103363,Sputum Cytology in Screening Heavy Smokers For Lung Cancer,0.0005271594613378779,0.0005449359408010588
NCT00155116,SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis,0.0004642954821176919,0.00040294218897614397
NCT00136890,PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers,0.0006674726726110922,0.0006557561252760686
NCT00136864,Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial),0.0006072625698780381,0.0005536608937433623
NCT00148395,Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.,0.0006768578079144958,0.0007216610907677908
NCT00191191,To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC),0.0007693620193765016,0.0010362885520460176
NCT00191308,Molecular Profiling in Lung Cancer Patients,0.0009061772837547197,0.000807385834832349
NCT00147537,"Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer",0.0006118810638677556,0.0006959302051102607
NCT00144053,A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer,0.0006968174698508201,0.0005976419198690839
NCT00153842,A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer,0.0007031676366692063,0.0006795110186025843
NCT00150657,Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer,0.000619815865251102,0.0005783784436773988
NCT00188890,Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers,0.0005241352204934023,0.00037344571285093754
NCT00188214,CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy,0.0004667331259718834,0.0006676435794245504
NCT00172042,A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC),0.0008028648565044673,0.0007146952684277683
NCT00115206,Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy,0.0006938142008470809,0.0007345795681778774
NCT00100256,Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy,0.000629872213948798,0.0006467692501281271
NCT00152477,A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer,0.0007457640247622786,0.0008642436026170392
NCT00132379,ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0008217701746785748,0.0008256940613967126
NCT00132522,"EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide",0.0006860562641297926,0.0006247004183768104
NCT00107250,"AZD2171 and Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)",0.0006502292092427444,0.0007161260192049919
NCT00181545,Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients.,0.0007466407440394482,0.0006367914693831956
NCT00108186,Celecoxib Treatment for Lung Cancer,0.0006979207803248765,0.0004093504746822892
NCT00175578,Detection of Early Lung Cancer by Serum Protein Expression Profiling,0.0005275952139714908,0.0005308939738492943
NCT00145418,Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer,0.0006870444915080969,0.0006716411680991672
NCT00126581,Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer,0.0007361239418382623,0.0008485178861800074
NCT00129844,Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer,0.0007177040883442202,0.0007190630420848534
NCT00180154,Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET,0.0006324676214599237,0.0009433499331664078
NCT00178256,Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer,0.0004875608332230751,0.0007124280479258231
NCT02178163,Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer,0.0008168040300444042,0.0008465060597294566
NCT02162537,Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases,0.0007740591116774702,0.0007960384227328823
NCT02172027,Immunomagnetic Detection of Cancer Cells in Pleural Effusion in Lung Cancer Patients as Additional Staging and Prognostic Tool,0.0005738129998383558,0.0006087388302917484
NCT02195336,dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.,0.0006433829349457831,0.0006362231351909918
NCT02134015,Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung),0.0007319815699812563,0.0007077969269164477
NCT02157883,"Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)",0.0007500722546581531,0.0006528622624102694
NCT02166658,A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet),0.0006643260915743967,0.0006313888699120352
NCT02166242,Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers,0.0006385157214431553,0.0006242248731960795
NCT02183870,EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer,0.0009043943093638058,0.0006841445882741707
NCT02111681,Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer,0.0004633613557657087,0.0006283578206979287
NCT02147990,"TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC)",0.0007820714750085713,0.0008385496478051974
NCT02193282,Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial),0.0007562860953840659,0.000849467365817746
NCT02135679,The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy,0.000746274405524845,0.0006313355223966595
NCT02152631,A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer,0.0007711128382996694,0.0011014700364587653
NCT02192697,An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations,0.0008393805530339698,0.0009251610207724952
NCT02133677,A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases,0.0006493706686002168,0.0005919242867392097
NCT02133508,A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib),0.0006505811836826677,0.0006170039196274143
NCT02117440,Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer,0.0005133011900359326,0.0005671477517027449
NCT02117908,Study of the Application of CPAP to Reduce Complications and Improve Lung Cancer Ablation Radiofrequency Treatment,0.0005225216746699711,0.0004951351515035898
NCT02179671,"Immune-Modulated Study of Selected Small Molecules (Gefitinib, AZD9291, or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer",0.000855093391443925,0.0007120315028899728
NCT02109016,"A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations",0.0006827547995436001,0.000644520074925819
NCT02109549,Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.,0.0007860178860414845,0.0008095107522406334
NCT02191059,Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer,0.0005224699334351044,0.0006499337058934465
NCT02191891,BI 836845 Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC),0.0007668727900224995,0.0008079707146278652
NCT02113813,A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations,0.0007515285688241395,0.0007107777195416868
NCT02113852,"Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients",0.0006359725189878072,0.000633165159742135
NCT02121379,Randomized Clinical Trial of 8 Weeks Pulmonary Rehabilitation in Advanced Stage Lung Cancer Patients With COPD During Cytotoxic Chemotherapy,0.0006416516623853137,0.0005443175413822034
NCT02121925,Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up,0.0005730427471873423,0.0005069848232391564
NCT02121899,Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006),0.0004694786419053076,0.0004781915920294512
NCT02121652,Cognitive Behavioral Therapy (CBT)-Insomnia for Lung Cancer,0.0008986078023327957,0.000999572708164471
NCT02199886,Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection,0.0007907320155504377,0.0007078247468868912
NCT02196844,Yoga Program for Lung Cancer Patients and Caregivers,0.0007251391624686081,0.0005883212851218067
NCT02149576,Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery,0.0004888235593365754,0.0006341265046242466
NCT02189967,Postoperative Radiotherapy of Non-small Cell Lung Cancer: Accelerated vs. Conventional Fractionation,0.0006658511565264737,0.0007408604265504852
NCT02186847,Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007599519031522236,0.0008687271613450323
NCT02185495,"Screening for Early Lung Cancer in Shanghai, China",0.0009027389581488428,0.0003454004717061799
NCT02151721,Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer,0.0005031790531995488,0.0004955674475333992
NCT02161523,The Impact of Lung Cancer-derived Fibroblasts on Mast Cells Activation,0.0006371240331475165,0.00041722792180789737
NCT02161991,Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers,0.0006665707921173102,0.00047153801651320993
NCT02145078,Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer,0.0007304940680432366,0.0008212248067573053
NCT02132884,Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007299295624064983,0.0007952093540371163
NCT02132325,Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer,0.0006461247145286601,0.0007703899433094158
NCT02182050,Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer,0.0008055318456927995,0.0007387721462285112
NCT02182232,A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer,0.0007348268238960925,0.0008421121727028963
NCT01102517,A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer,0.0005769309326709838,0.0006399597792195829
NCT01102231,Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC),0.0006766549335494613,0.0007667038659377446
NCT01188707,A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer,0.0007669981066261577,0.0008873046950926718
NCT01188486,Pulmonary Interstitial Lymphography in Early Stage Lung Cancer,0.0004919858982849776,0.0007120797593891836
NCT01140958,A Retrospective Pharmacoeconomic Study of Lung Cancer,0.0010973335861418593,0.0004691041347616339
NCT01171924,"A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors",0.0006742009688368634,0.0006223379947941154
NCT01161173,An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non-small Cell Lung Cancer,0.000765134304347414,0.0007529922344887957
NCT01179685,Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer,0.0005914009927703609,0.0005616457030665592
NCT01179308,Regional Anesthesia and Lung Cancer Recurrence,0.0006383300864952306,0.00042799867818241216
NCT01159964,"Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery",0.0007229801459390032,0.0008436653778188228
NCT01189435,Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib,0.000601283020357719,0.0006613617059570999
NCT01153984,A Study of Tarceva (Erlotinib) in Patients With Advanced and/or Metastatic Non-small Cell Lung Cancer With EGFR Positive Mutation (BIOTEC),0.0008326454020048019,0.0007489926412533772
NCT01153399,A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).,0.0008843427602425821,0.0008111552081572608
NCT01194453,Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung Cancer,0.0006645505662690589,0.0005954630304421528
NCT01158170,Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT1001),0.0006294631090623401,0.0006112725743304058
NCT01172314,Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients,0.000733825040318769,0.0006107426320906711
NCT01196234,Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer,0.0006739083863667052,0.0007328149651813315
NCT01141946,Pleural Ultrasonography in Lung Cancer,0.0009015365559615103,0.0006571518592724654
NCT01138163,Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer,0.0008342417668610236,0.000804570910836323
NCT01138358,Study of Episodic Breathlessness in Patients With Lung Cancer or Other Advanced Disease,0.0006886295921789096,0.0006311597713213218
NCT01138748,Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers,0.00047255790530640175,0.0005878436972720781
NCT01138722,Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial,0.0006412356659646574,0.0006558488777743427
NCT01130766,Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC),0.0006703908154478329,0.0006457895343999787
NCT01130285,Validation of a Multi-gene Test for Lung Cancer Risk,0.0006422720344815055,0.0006816899041276179
NCT01130714,Resistance Training in Lung Cancer Patients on Chemotherapy,0.0007542824543757989,0.0006827866536095676
NCT01160601,Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer,0.0006594798103862356,0.000834868564966267
NCT01133067,Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients,0.0007254318942605761,0.0006681795918295438
NCT01109524,Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer,0.0006974799746072815,0.000836082782908197
NCT01192256,Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer,0.00047071421269576715,0.0003380667729655862
NCT01192230,Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients,0.0008473810207402379,0.0009323311542983452
NCT01192919,Tumour Registry Lung Cancer (TLK),0.0006579227405103074,0.0007021887824213462
NCT01121393,BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC),0.0006051719807324478,0.0006466410582933946
NCT01134861,Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0008615514098102593,0.0007630839660822046
NCT01137968,Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC),0.0006124948903117557,0.0007331947544957529
NCT01165216,Japanese Study of Ipilimumab Administered in Combination With Paclitaxel/Carboplatin in Patients With Nonsmall-cell Lung Cancer,0.0006718718495856457,0.0008717895225541515
NCT01124864,A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy.,0.0007417449817933933,0.0006910515487585455
NCT01117714,Surgical Versus Non-surgical Staging of Lung Cancer,0.0006684829362908929,0.0006280835089352934
NCT01125995,Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer,0.0005581459584795652,0.0007110116591305349
NCT01178190,The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer,0.0006403369683196695,0.0005330210994920207
NCT01112631,Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy,0.0008272682613788637,0.0006440718450993176
NCT01170923,FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer,0.0006381695996419402,0.00048052771852662623
NCT01199068,CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC),0.0006714486244483267,0.0007700070467934387
NCT01199055,CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC),0.0006576106390790788,0.0007254369792562009
NCT01147562,Biomarker Discovery and Validation in Lung Cancer,0.0009240438794448346,0.0006350482828295142
NCT01182155,Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation,0.0006237724621841474,0.0006240587366233208
NCT01185314,To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008273691386022439,0.0008514567636965768
NCT01185639,Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer,0.0007582566778999762,0.0006771668299585653
NCT01176383,Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers,0.000528520028888571,0.0003687405375820325
NCT01176487,Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34,0.0006624592129546663,0.0005779130594402995
NCT01193881,RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer,0.0008138893374745621,0.0007916136419178565
NCT01193959,Pemetrexed in Advanced Non-small Cell Lung Cancer,0.0008217385563680327,0.0006090622873986316
NCT01136083,Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients,0.000585524813511851,0.0005015919326308611
NCT01167530,Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer,0.000717125919943204,0.0006474884543531801
NCT01114958,Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases,0.0006397240469393831,0.0006169510995433427
NCT01101334,Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer,0.0007329149271965481,0.0008138418034861233
NCT02043665,Systemic Treatment Of Resistant Metastatic Disease Employing CVA21 and Pembrolizumab in Non-small Cell Lung Cancer and Bladder Cancer (STORM/ KEYNOTE-200),0.0005831736485837466,0.000676809016722386
NCT02016209,Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer,0.0005561067684963253,0.0005236565556075116
NCT02016872,"Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients",0.0007263487810376971,0.0007308636665306124
NCT02039674,A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Lung Cancer (MK-3475-021/KEYNOTE-021),0.00055617894997172,0.0007074813514955041
NCT02000531,Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population,0.0006821383955430494,0.0007562015900873098
NCT02000947,A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer,0.0007365834489116373,0.0009418619760916289
NCT02000518,Emergency Radiotherapy in Metastatic Spinal Cord Compression of Patients With Non-small Cell Lung Cancer,0.0007470437987202301,0.000660451477236302
NCT02070497,Effectiveness of Nursing Case Management for Lung Cancer Patients,0.0006298878841338989,0.000893460174862893
NCT02034097,A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer,0.0007280875411184375,0.0006021617377192011
NCT02054052,Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer,0.0004681200902458301,0.00040746656649650855
NCT02009436,Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer,0.0007937292849700868,0.0008628927722179348
NCT02009319,Endobronchial Ultrasound Elastography: the Utility of Strain Ratio for Lymph Node Staging in Lung Cancer Patients,0.0005617400819102158,0.0005819647114950733
NCT02093962,Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer,0.0007983387543251753,0.000984856377930518
NCT02001168,Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB,0.0006346428272488068,0.0005835341471577615
NCT02066870,Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI,0.0007243332785775257,0.0006658670571757
NCT02062515,Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency,0.0007309655490114805,0.0010795646199277494
NCT02024113,LC-NMR Study Biomarkers to Detect Lung Cancer,0.0007870833563716842,0.0005524425899579918
NCT02094950,Acupuncture Feasibility Trial for Dyspnea in Lung Cancer,0.0006406400705702471,0.00036925211573004386
NCT02087176,A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer,0.0005607699659660426,0.0007889336516187061
NCT02087241,Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer,0.0005573861837206057,0.0008720039812846229
NCT02031601,Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer,0.0007546546911860645,0.0006965651581063045
NCT02098954,Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers,0.0006761648857811367,0.0006702308462471351
NCT02049151,Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer,0.0009138838874736801,0.0006271696325537534
NCT02083679,Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer,0.0009314681034054645,0.0005328548009043534
NCT02018523,Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer,0.0006657107087918362,0.000837066602118501
NCT02079636,A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC),0.000535597691063148,0.0006786735679621592
NCT02004184,Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy,0.0006257080256747093,0.0008294595838696692
NCT02075957,"Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer",0.0005699170391084878,0.00052674502823964
NCT02027428,Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer,0.00068784585464163,0.0008904343336360764
NCT02027090,High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease,0.0007589460160305233,0.0007647784701829561
NCT02029209,To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008097917529669046,0.0008072016415257795
NCT02014324,Single Scope Staging of Lung Cancer With Endosonography,0.0006398425036372528,0.0006811218081737991
NCT02073968,PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer,0.0007301990874049182,0.0008941061992633271
NCT02050100,Biomarkers for Diagnosis of Lung Cancer,0.0006676744651672261,0.0006122458154259839
NCT02007070,Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025),0.0007874682181124651,0.0009042988144424157
NCT02007538,Thin Prep Versus Traditional Cytological Procedure for Lung Cancer,0.0008986078023327957,0.00043748453946071387
NCT02095808,Feasibility Study Using Imaging Biomarkers in Lung Cancer,0.0005399524304512515,0.0005237143480944525
NCT02095782,Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation,0.0005092463912240801,0.0005064014501572719
NCT02067858,An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System,0.0005945984966148347,0.0007674869496790865
NCT02084823,Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells,0.0005913815840320011,0.000526645920505248
NCT02030444,Extensive Staging in Lung Cancer,0.0017169554734706223,0.0005260389891508719
NCT02069418,Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient,0.0008552419526330827,0.0009288269371819097
NCT02040870,LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib,0.0007881980609337277,0.0007691018820291328
NCT02063828,Reducing Lung Cancer Survivors' Anxiety and Dyspnea (RELAX),0.0006394781217414737,0.0007245412609211926
NCT02059889,Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer,0.0005601203911854917,0.0006711517378066293
NCT02055170,Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer,0.0008031737852675283,0.0007214536406231318
NCT02044601,Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT),0.00047228512139732586,0.0005652907298769055
NCT02002117,Genotyping of Non-small Cell Lung Cancer,0.0009139101185727294,0.0009484310161425745
NCT00965731,"Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer",0.0007428177122893437,0.0008859052773601152
NCT00983047,Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer,0.0007710574750341922,0.0006092921416163986
NCT00983307,A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer,0.0008676627636500634,0.000889052710972613
NCT00955305,"Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer",0.0007412568316328862,0.0008387003942066192
NCT00950365,Pharmacodynamic Separation of Pemetrexed and Erlotinib as Second-line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008062305483219293,0.0007779331690809973
NCT00910546,Image Guided and Breathing Adapted Radiotherapy of Early Stage Lung Cancer,0.0004921223077169845,0.0005491784892571151
NCT00958555,A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer,0.0008222708223838992,0.001007679642173366
NCT00967083,Support Needs and Preferences of Family Caregivers of Lung Cancer Patients,0.0006308887367181175,0.0005218430624859463
NCT00920010,S9925: Collecting and Storing Samples From Patients With Lung Cancer,0.0012981398033125688,0.0007478585662780887
NCT00973427,DNA Chip Based Prognosis of Lung Cancer,0.0008991957304839702,0.0007734861519265991
NCT00973310,Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer,0.0007170235452278501,0.000982491392361606
NCT00993499,Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib,0.0007278122022553026,0.0006691887037522681
NCT00923884,Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer,0.0006979308557875507,0.0007271717920411772
NCT00923949,Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer,0.0007516332566795951,0.0008952144298699928
NCT00995761,Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC),0.0007271565458288056,0.0008504100901826983
NCT00906282,"Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer",0.0006905247781441825,0.000713111980292647
NCT00979888,Study of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung Cancer,0.0006600467335657425,0.0005062381415475842
NCT00940069,TS Gene Polymorphism Predicts Effect in Patients With Advanced Lung Cancer,0.0010122121607690356,0.0007182489323075833
NCT00997724,Assisted-VATS Sleeve Lobectomy for Non-small Cell Lung Cancer,0.0007298741994868694,0.000704524782043995
NCT00900419,"Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",0.0005614144935553842,0.0005483285998600259
NCT00900328,Study of Tumor Samples From Patients With Lung Cancer,0.0008375400824905564,0.0007306867087686653
NCT00900835,"Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer",0.0005532718376020226,0.00040671309181022
NCT00905801,Computed Tomography (CT) Perfusion Imaging of Lung Cancer,0.0006394906443569864,0.0006795840000136417
NCT00994097,NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer,0.0007787518256584276,0.0008225488152091261
NCT00954278,Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer,0.0007843188678264366,0.0007678125187695408
NCT00984243,Photodynamic Therapy (PDT) in Lung Cancer,0.0009009010255788557,0.0005514379396151548
NCT00985998,Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer,0.0007739016661085378,0.0007824491351423181
NCT00988858,A Study of Advanced or Metastatic Non-small Cell Lung Cancer,0.0008065461594214898,0.0008523690509692727
NCT00960115,Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy,0.0006677714138218248,0.0008938653442029915
NCT00991796,CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC),0.000628645178041702,0.0007329182569139765
NCT00913705,Neoadjuvant or Adjuvant Chemotherapy in Patients With Operable Non-small-cell Lung Cancer,0.0007257588188433572,0.0008125279533690096
NCT00970645,Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer,0.0006267155341249128,0.000502786214433187
NCT00956852,Study on Systemic and Airway Cytokines and Oxidative Stress in Lung Cancer Patients Undergoing Surgery,0.0006467734452086702,0.0006197703093365915
NCT00071188,ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006771521897169202,0.0007230633712450484
NCT00071344,Analysis of Brain Metastasis in Patients With Lung Cancer,0.0009131200712343717,0.0007729104752177163
NCT00006017,Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer,0.0007937790154849475,0.0007839084603106373
NCT00006484,Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007408867331467599,0.0007513502860570765
NCT00006470,Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery,0.0007359209834471504,0.0008566879230993998
NCT00006212,Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer,0.0007450818702908189,0.0008596237317915168
NCT00006229,Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer,0.0007990982573685679,0.0008005042927471588
NCT00006019,"Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer",0.0006790978773857939,0.0007674129201145814
NCT00006877,Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer,0.0008247438887101652,0.0009370829633502008
NCT00006929,"Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer",0.000743540036712486,0.0008997718344997015
NCT00006087,Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer,0.0005625596726876266,0.0004098883819276994
NCT00006378,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007786443167823116,0.0007676084284646855
NCT00006004,Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer,0.0006411242570265911,0.0006677026166859605
NCT00084409,Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease,0.0006333544009474678,0.0006065766811639462
NCT00033527,INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer,0.00047020332448922795,0.0003846253879187753
NCT00016237,"Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment",0.0005909033827781722,0.0006460306637846233
NCT00063219,Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy,0.0007568775826817839,0.0009046986033253833
NCT00063258,Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer,0.0006881244140582417,0.0007952155050121129
NCT00063388,Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer,0.0010321614941224677,0.001202991208723305
NCT00085839,Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2,0.0007982026836540829,0.0008161427160729403
NCT00078260,A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer,0.0007345228302131643,0.0006754857376483639
NCT00074295,S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer,0.0006739526685167976,0.0006065110828433252
NCT00014066,Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer,0.000723189079505422,0.0006518583093423044
NCT00049790,Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer,0.0007938655682846702,0.0008279015548966553
NCT00049543,"Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery",0.0007349332808649682,0.0008711893729148523
NCT00047840,This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.,0.0008296078182615721,0.0010029183026617188
NCT00047736,A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer,0.0007126034021532208,0.0008760419385862087
NCT00019006,"Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer",0.0006310923005804395,0.0006402469824733742
NCT00019201,Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer,0.00046465589779018813,0.000546724157703345
NCT00003053,"Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed",0.0007525989544118653,0.0007668694291844051
NCT00003762,Docetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007497654456546411,0.0007656999298606089
NCT00003089,"Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer",0.0007880458129891192,0.0008380917883999109
NCT00003869,Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer,0.0007524774862617712,0.0007822642292559315
NCT00003881,Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008169934854107914,0.0008287685048902201
NCT00003159,Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer,0.0008203110212815456,0.0007697700988687133
NCT00003090,Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer,0.0009306515403633731,0.0009045745247844142
NCT00003313,Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer,0.0007456444389561289,0.0007744752656652448
NCT00003284,High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer,0.0006389269993482207,0.0007643627415825361
NCT00003111,Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007849411939246227,0.0009061410173693684
NCT00003072,Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer,0.0007597785220194755,0.0008621159254576559
NCT00003117,Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008205583220795327,0.0008248691915879989
NCT00003202,Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0007744840618027024,0.0007610478796029973
NCT00003803,"Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed",0.0007785740737545435,0.0007610325036033648
NCT00003240,Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0007762104135556079,0.0007979228498045104
NCT00003062,Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer,0.0009320906549174288,0.0008815343418116081
NCT00003974,"Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma",0.0007305796101810041,0.0007966985451080144
NCT00003002,"HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer",0.0007057774387799114,0.0007465618862294951
NCT00003589,Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008745404151175902,0.0007697292676125492
NCT00003901,"Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery",0.0007996666981491183,0.0008310479220523078
NCT00003154,Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008951283313996135,0.0009426647672328153
NCT00003587,S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000776914797494774,0.0008877153184912341
NCT00003831,Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer,0.0007312361403746837,0.0007073918699154286
NCT00003692,Video-Assisted Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0009306460831108083,0.0008675987726938107
NCT00003231,Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0008271691029700694,0.0009143925590679907
NCT00003562,Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000757954348342593,0.0009226746709441513
NCT00003006,Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer,0.0007685411116990975,0.0006725217594310801
NCT00003900,Irinotecan With Docetaxel in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer,0.0007657765210645402,0.0009099127687691161
NCT00003317,Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007971394050175091,0.0007710335228154199
NCT00003037,Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.000751354696917245,0.0008705426923676021
NCT00003599,Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer,0.0004373205569257267,0.0005521626546911207
NCT00003685,Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer,0.0008359338583657153,0.0007269585212188584
NCT00003387,"Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery",0.0007574664286824517,0.0007725242964779766
NCT00003235,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed,0.000746593129058875,0.0007768575860919769
NCT00003989,"ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma",0.0007593131151676485,0.0008852019568776261
NCT00003666,Irofulven in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer,0.0008030703484724849,0.00092067418392981
NCT00003158,S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007786443167823116,0.0008808901516354064
NCT00088933,Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer,0.0005894856164745657,0.0006678495454826657
NCT00008385,Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer,0.0007240800015719728,0.0007406779585864841
NCT00008255,INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer,0.0007379138615925502,0.0006492317015345564
NCT00055978,Celecoxib in Preventing Lung Cancer in Former Heavy Smokers,0.0006450623550708235,0.0006403369707727099
NCT00040560,Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer,0.0005329406139593608,0.0005537040578900168
NCT00040768,Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer,0.000867912648762036,0.0008857186204737917
NCT00034957,Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC),0.0008375001440562158,0.0010423380457528764
NCT00034697,Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143),0.0005903569566109764,0.0006105322534186113
NCT00034346,ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006892064756856598,0.0006325205195501472
NCT00077883,TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006611274846735395,0.0007883281053965264
NCT00043823,Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer,0.0006677380999336055,0.0006758505664777062
NCT00099879,Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer,0.0008900334712782938,0.000994419227481137
NCT00048087,Iressa/Docetaxel in Non-Small-Cell Lung Cancer,0.0007448600226101487,0.0007457960707264438
NCT00059605,Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer,0.0008293183945426451,0.0008002399835908943
NCT00021008,ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer,0.0009076717457437753,0.0008692353750722806
NCT00021333,Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer,0.0006087370676920437,0.0007073620042929868
NCT00020202,FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer,0.0009318014268933338,0.0009644639098432291
NCT00020007,Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery,0.0005823966514493378,0.0005567412735044953
NCT00002519,Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer,0.0007535025395115112,0.0009137781060129525
NCT00002667,Early Detection of Second Lung Cancer in Patients With Stage I Non-small Cell Lung Cancer,0.0008358082019485055,0.000755002451443211
NCT00002484,Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer,0.0007985161274357617,0.0008282999456873342
NCT00002550,Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer,0.0007935411993318971,0.0007946449204593896
NCT00002623,Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007763942607840936,0.0007740678987125446
NCT00002583,Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed,0.0007470675821263373,0.000800116738383661
NCT00002537,Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer,0.0008352636158587214,0.0009243415601280485
NCT00002823,Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer,0.0007912008884803459,0.0008327278126932078
NCT00002911,Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer,0.000811438396713199,0.0007233865204888613
NCT00002577,Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer,0.0009710575220545961,0.0008642607903474926
NCT00002969,S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007845927832928372,0.0009430625070807341
NCT00002972,Paclitaxel in Treating Patients With Lung Cancer,0.0009295310589812637,0.0008186408445398709
NCT00002624,Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function,0.0007343197223062142,0.0008168435751293259
NCT00002642,"SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer",0.0007763942607840936,0.0008828378084960924
NCT00002852,Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer,0.0008032946276310846,0.0008049419149831023
NCT00002887,Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer,0.0008072350441523478,0.0009471310406253023
NCT00002656,Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008676810777335555,0.0009601643002306585
NCT00005868,Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer,0.0007496810699773384,0.000931497462436578
NCT00005065,"Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer",0.0007935411993318971,0.0008875297232299709
NCT00005989,R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer,0.0008233051197154453,0.0009363675585328768
NCT00005055,Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007925072965091046,0.0008140311464237804
NCT00005037,"Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007722938006352558,0.0009311897158479031
NCT00005071,Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer,0.0006772400385305791,0.0006726603681004331
NCT00005872,Nitrocamptothecin in Treating Patients With Recurrent Non-small Cell Lung Cancer,0.0009303593844391501,0.0009635640216815295
NCT00005825,Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000776914797494774,0.0009355865948042621
NCT00005091,DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007391975073511729,0.0009161666142796967
NCT00005838,Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery,0.0007397286413267426,0.0007557386758829317
NCT00005093,Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008736274608509387,0.0008002974626129599
NCT00005883,Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke,0.0006383017097835432,0.0005173802243077201
NCT00005666,Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer,0.0005664245264424652,0.0006986612634773271
NCT00005849,"Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007474679298426266,0.0009114335582158561
NCT00005630,Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer,0.0008029852121348868,0.0007432863413582366
NCT00086268,Non-small Cell Lung Cancer Study US75 (Z-PACT),0.0010459577960904261,0.000828139571339047
NCT00050973,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",0.0007605411312503753,0.0008873480907457363
NCT00050960,"Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer",0.0007605411312503753,0.0008873480907457363
NCT00004264,"Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer",0.0007753692688722503,0.0008579046055546053
NCT00004930,Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases,0.0006303786718811838,0.0007946836143674512
NCT00004011,S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer,0.0008271691029700694,0.0007860409031525936
NCT00004138,Positron Emission Tomography for Detecting Non-small Cell Lung Cancer,0.000928778034637392,0.0007542651234353392
NCT00004209,Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000776914797494774,0.0008025477281722709
NCT00004160,Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed,0.0007626396647807101,0.0008840684593055324
NCT00004126,Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer,0.0008065110555682216,0.0009295974026206217
NCT00004265,Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer,0.0009500294052934517,0.0009774797336784182
NCT00004096,Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.000749923978520423,0.0009148867832217599
NCT00004887,Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery,0.0007581716884347794,0.000769947531993638
NCT00004253,Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery,0.0007417405555624163,0.0009104497300138764
NCT00004202,"Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer",0.0007429414711753073,0.0008667783911492311
NCT00004199,Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer,0.0007593890195443329,0.0007308800056743651
NCT00004159,Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor,0.0007565145821285028,0.0008640667717045116
NCT00004093,Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007786443167823116,0.0008766880443446221
NCT00004238,10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007709721559115255,0.0009305143043860411
NCT00004100,Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007952682312012358,0.0007699641747988037
NCT00004924,Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008077632834517398,0.0008454794456302136
NCT00004139,Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007348255860094113,0.0007801351413240585
NCT00004151,Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0008676810777335557,0.0009245940946259138
NCT00004979,Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors,0.0007634599783239502,0.0008783947964155386
NCT00004201,"Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer",0.0007454722573873985,0.0007786199776247864
NCT00004859,"Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer",0.000745352564159283,0.0007589365192481098
NCT00004883,Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2,0.000771161084627587,0.0007961812114996385
NCT00080509,Effectiveness of KOS-862 in the Treatment of Lung Cancer,0.0006991211417302945,0.0008145857860803521
NCT00024076,Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer,0.0008033232175323324,0.0009032120062307594
NCT00035152,Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer,0.0006574071962318184,0.0007868142289550275
NCT00056004,Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia,0.0006299484416161612,0.0006677097795517973
NCT00061997,Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers,0.0006342986055853288,0.0005260245297970744
NCT00090961,"S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer",0.0006034102641844589,0.0005019475351283094
NCT00097903,Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer,0.0007357447489252355,0.001028949607685249
NCT00097851,Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0007433128507008094,0.0007786997685861034
NCT00031785,Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer,0.000761774611032939,0.0005847009009106757
NCT01408212,Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients,0.0007239279258399462,0.000884291582133459
NCT01456429,Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.,0.0005243103345466652,0.00045162026854681924
NCT01429766,A Prospective Study of Variation in Breath Holding Times at Various Phases of Respiration During the Course of Radiotherapy Including the Effect of Respiratory Training in Lung Cancer Patients,0.0006461169888177073,0.0005189289371065233
NCT01427946,Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer,0.0006467839110634395,0.0007922603286598844
NCT01454102,"Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)",0.0007099683987547976,0.0006642044320017016
NCT01460472,Immunotherapy With Racotumomab in Advanced Lung Cancer,0.0006053501915452938,0.0006891544426994421
NCT01465854,French Biological Observatory on Lung Cancer in Never Smokers,0.0006442966697538487,0.00044367522593353315
NCT01419587,Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG),0.0006416059604992332,0.0008129754363864975
NCT01466946,Understanding Symptom Recognition and Treatment Decision-making in Hispanic/Latino Lung Cancer Patients,0.000592301294140271,0.0007827874978868408
NCT01466647,A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC),0.0005478680486729744,0.0006223692676527869
NCT01421953,Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers,0.0006261764974707715,0.0006343315218210753
NCT01407822,Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer,0.000687731696559808,0.0006876904875920768
NCT01433172,Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer,0.0005517368687049633,0.0006765828792262092
NCT01433263,Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas,0.000666502154069141,0.0008758254619476585
NCT01482182,"Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy",0.0007098785461226035,0.0007586937236065018
NCT01494883,Mindfulness for Lung Cancer Patients and Partners,0.0009038177165653493,0.000814118436504051
NCT01441349,Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer,0.0006979191123260454,0.0007973012723814586
NCT01444118,A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients,0.0007772516729739669,0.0008441491972064112
NCT01411098,"Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007435566081376241,0.0008378236468085987
NCT01493843,Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer,0.0008118130737737953,0.0007880499189323749
NCT01457469,Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer,0.0006347618337280694,0.0006826695293541771
NCT01452971,A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer,0.0005579068369525646,0.00048083501217581096
NCT01443078,"Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)",0.0007623355151057789,0.0008378635847146105
NCT01416688,"S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride",0.0005523122842127784,0.0005132189920575653
NCT01481259,Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung Cancer,0.000588307970247206,0.0007702964441440622
NCT01424709,Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC),0.0007584087970356108,0.0006964065743400836
NCT01497041,"A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment",0.0007696733358288207,0.0007861896966318254
NCT01415011,Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients,0.0008267195508655981,0.0008873085041077892
NCT01487603,Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer,0.0009034311467531367,0.0006749952460679523
NCT01473693,Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging,0.0006548958512810261,0.0006434830278400245
NCT01413737,Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days,0.0005883423249783791,0.0008714902194438025
NCT01475500,Nashville Early Diagnosis Lung Cancer Project,0.0006438660135511563,0.0004391245951491926
NCT01498562,Phase II Study of Gefitinib Plus Nimotuzumab Versus Gefitinib in Non-small Cell Lung Cancer,0.0007217830927717386,0.0006151338729954222
NCT01498055,Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study,0.0005164409809691091,0.0007485780992628359
NCT01296113,Chemotherapy for Lung Cancer in HIV-positive Patients,0.0007617593156005656,0.0008117973793702174
NCT01284348,Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small Cell Lung Cancer,0.0008593509332285602,0.0009254722338475823
NCT01221077,Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene,0.0008527240942105727,0.000808619828686305
NCT01287754,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations,0.0008323541208167927,0.0007459865864038749
NCT01287962,Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer,0.000739333569784883,0.0007764609590399583
NCT01270399,Targeting ER-Golgi Homeostasis in an Advantageous Therapeutic Strategy in Lung Cancer,0.0004985089326262732,0.0003894408863384207
NCT01270386,A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer,0.0008698141081745532,0.0007829293613898117
NCT01213745,The Use of a Quality of Life Questionnaire in Patients With Lung Cancer,0.0007255492631979252,0.0007754017798779112
NCT01266512,Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer,0.0004760366941573842,0.00038540640948931987
NCT01261585,Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT,0.0007232623048794542,0.0004929128914269657
NCT01259284,Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer,0.0005620523521950877,0.0005403536758343428
NCT01282450,Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC),0.0007586004616760559,0.000878700510713356
NCT01282151,TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer,0.0006499681064689767,0.0007190254256140025
NCT01210378,Nitroglycerin in Non-small Cell Lung Cancer,0.0009127295406102974,0.0007092833861347947
NCT01219348,IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.,0.0006406935371098906,0.0005257388410147055
NCT01203735,Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer,0.0007296329164085523,0.0005439438681358092
NCT01246297,Effect of Pulmonary Rehabilitation in Lung Cancer Survivors,0.0009020868590749516,0.0005186471629219227
NCT01280448,"The Correlation Between Lung Cancer Susceptibility, Drug Response and Genetic Polymorphism",0.00046954018720344844,0.0005065007757302018
NCT01281787,PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer,0.0008997889711793395,0.00044122731815762967
NCT01291017,"Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.",0.0006399530498836501,0.0008068622462997373
NCT01262560,Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer,0.0006002087156386617,0.0005009489549371408
NCT01262820,Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab,0.00047809573215574054,0.0005529725728408751
NCT01211483,Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer,0.0007329149271965481,0.0008073321572739721
NCT01211002,Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC),0.0007103146058243144,0.0009021156837014628
NCT01240447,Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients,0.0007742963025444667,0.0008171850360258756
NCT01240369,Association Between VEGF-C and miRNA and Clinical Non-small Cell Lung Cancer and Esophagus Squamous Cell Carcinoma,0.000638604852459363,0.0006474018827049146
NCT01263886,Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer,0.0007191421597410832,0.0007774999513680289
NCT01297491,Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer,0.0009584194930375868,0.0008693108032614323
NCT01218594,Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer,0.0006227267007531106,0.0007500628897886509
NCT01274468,Tumor Markers in Lung Cancer,0.0006727036873928659,0.0008815239799699618
NCT01244191,"ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer",0.000588571408849063,0.0006368385562767723
NCT01257308,Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients,0.0005988986132307443,0.0008486666156663898
NCT01207011,Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer,0.0009303593844391501,0.0010362014104805157
NCT01207063,Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC),0.0008079481985917335,0.0006743779712576175
NCT01201044,Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC),0.0007107078412897254,0.0010309339319873876
NCT01230710,A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression,0.0008506845921392039,0.0008100386597073429
NCT01278888,"Minimally Invasive or Open Surgery for Lung Cancer: Pain, Quality of Life and Economy.",0.0004651550539472622,0.0005263678679346489
NCT01258478,Lung Cancer Rehabilitation Study,0.0007711129022918446,0.0005677900396447328
NCT01258127,Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC),0.000727601838249707,0.0006933552947600424
NCT01290809,Prophylactic Cranial Irradiation (PCI) Cognitive Tests in Non-small Cell Lung Cancer (NSCLC) Patients,0.0007642283495433273,0.0006931798285399412
NCT02941003,Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer,0.0005014144069173763,0.0005081450776004015
NCT02921191,"Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated",0.0006299685430592383,0.0005688028504958062
NCT02917369,Integrative Analysis of Large-cell Lung Cancer,0.0017169554734706223,0.002469300511630684
NCT02907606,Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study,0.000734425904232404,0.0008476311842136755
NCT02973789,Effect of Tumor Treating Fields (TTFields) (150 kHz) as Second Line Treatment of Non-small Cell Lung Cancer (NSCLC) in Combination With PD-1 Inhibitors or Docetaxel (LUNAR),0.0006042326468906148,0.0007165416797777474
NCT02997449,Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered,0.0007214757626678326,0.0008833432867622831
NCT02954809,"Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors",0.0004343612936831958,0.000550613726233755
NCT02980809,Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer,0.0005042952551251829,0.0008021485781120932
NCT02938546,18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study,0.0006447554822576313,0.0006595497035799867
NCT02904954,Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer,0.0006718493987235062,0.0008252275206336536
NCT02968979,Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.,0.0007767470958739856,0.0008785198830276727
NCT02956551,Neoantigen-primed Dendritic Cells (DC)- Pre-activated T (PreT) Cell Therapy for Refractory Non-small Cell Lung Cancer,0.0007315946619617336,0.0010141888360366128
NCT02992353,"Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer",0.000732018224441532,0.0006535951529244682
NCT02994576,Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer,0.0007318781054000127,0.0006792094403638618
NCT02936323,PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers,0.0007040349610870155,0.0006791736369487969
NCT02936804,Precision Diagnosis and Therapy for Early Stage Lung Cancer,0.0006142661912930977,0.0005403876299910075
NCT02978521,Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients,0.0008697826093161039,0.0007829193288362858
NCT02931461,Interest of Procore Needle® for Diagnosis of Lung Cancer,0.0005302011310340675,0.0004863076538649797
NCT02984761,Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy,0.0009009484905608537,0.0008181670400795339
NCT02963610,Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer,0.0007854524819147944,0.0007887592744514858
NCT02989974,Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program,0.0009038522787807324,0.00046381280272592
NCT02961270,Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation,0.001179452863618734,0.0012407119725576627
NCT02965391,Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients,0.0006628315565310121,0.0006614415487989798
NCT02962115,Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention,0.0005268121822960775,0.000587394810014925
NCT02974933,Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer,0.0006866647783379974,0.0008452274199077627
NCT02991924,Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer,0.0005218220136561777,0.0004604748709700605
NCT02933294,Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer,0.000561441534281164,0.0004824223777131361
NCT02927340,A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions,0.0005656825660812768,0.0007709670835514863
NCT02976116,A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer,0.0008267524471121539,0.0007757616668015905
NCT02922777,Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.,0.0013112651325000633,0.0009329528288354469
NCT02995889,FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer,0.0005966930196690662,0.0007337124200189265
NCT02959619,Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALK,0.0008067658553822972,0.0009928361496476209
NCT02942043,Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer,0.0006790405089997815,0.0009148456488266823
NCT02971501,Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases,0.0007139074622598372,0.0007609506884221367
NCT02955758,Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer,0.0008271558565230111,0.0009716856592523716
NCT02955290,CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007662098681733752,0.0008352339692553893
NCT02972177,Transbronchial Ablation for Peripheral Lung Cancer,0.0008992088267465387,0.0009098430306751193
NCT02966769,N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation,0.00048745893585292117,0.0006484108995920627
NCT02947386,Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007969903986715707,0.0007740792537939478
NCT02967133,A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer,0.0007218417171333106,0.0007020975592325229
NCT02937818,"A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer",0.0008267479538735344,0.0008468038679088012
NCT02916147,Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy,0.0005861066042452145,0.0005512565051418397
NCT02916745,Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer,0.00043687435073773174,0.0006217816852687073
NCT02538380,EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients,0.0007217630644382768,0.0011702072511921902
NCT02500810,Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients,0.000606913377302767,0.0006780609078208903
NCT02589522,VX-970 and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer,0.0007716396155245296,0.0008273527533625667
NCT02507518,Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer,0.0005289730233120661,0.000817641610663578
NCT02542930,Abscopal Effect for Metastatic Non-small Cell Lung Cancer.,0.0007555790477891415,0.0008337465514765641
NCT02542293,Study of 1st Line Therapy Study of Durvalumab With Tremelimumab Versus SoC in Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE).,0.0006704416500544436,0.0006739373680375918
NCT02566993,"Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin (DOX) Versus Cyclophosphamide (CTX), Doxorubicin (DOX) and Vincristine (VCR) (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer",0.0007105797398624481,0.0005883945758269835
NCT02578680,Study of Platinum+Pemetrexed Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Non-squamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189),0.0006772899224351301,0.0007035655832051982
NCT02504801,Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD,0.0007210853789403616,0.0005234436390841414
NCT02504372,Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091),0.0006281679846368469,0.000677702255838799
NCT02504697,DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer,0.000665514051350817,0.000539658695816073
NCT02504346,"AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies",0.0008035359594159678,0.0007935576866317741
NCT02570815,Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer,0.00046063748554043144,0.0004144921998067804
NCT02519972,Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer,0.000434588549959421,0.0003673060447887753
NCT02573506,Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer,0.0007176421180358658,0.0008118736575627234
NCT02556593,IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases,0.0006556723309677474,0.000815942812109211
NCT02502318,Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung Cancer,0.0005595580518472427,0.0005974128289574382
NCT02502695,A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS),0.0008252270152624002,0.0006344533253377404
NCT02505685,Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer,0.0005780235422240066,0.000782543923927859
NCT02588261,A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations,0.0008283933734962298,0.0008616899287159044
NCT02520778,Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer,0.00076199033937777,0.0008378785602483812
NCT02540174,Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction Treatment,0.0005809857651036523,0.0005944485252667883
NCT02540824,Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer,0.0007191865027968321,0.0007483620443674568
NCT02551211,Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer,0.0006003079507644688,0.0007404739166989141
NCT02513355,Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research,0.0006530282999631838,0.0005756624651340783
NCT02579005,Radio-Immuno-Modulation in Lung Cancer,0.0006367381837594436,0.0005347368515059122
NCT02577393,Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy,0.0006575628384896398,0.00061309961904241
NCT02596490,Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners,0.0006514181331599883,0.000411130401999485
NCT02596958,Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants,0.000636543657849772,0.0006713701990208955
NCT02572843,Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC),0.0008065522804625029,0.0006067345763057435
NCT02511288,LIquid BIopsies in Lung Cancer (LIBIL),0.0017169554734706223,0.0006210467020398245
NCT02535325,"Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer",0.0007473937084535079,0.0008563803729360895
NCT02535338,Erlotinib Hydrochloride and Hsp90 Inhibitor AT13387 in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer,0.0007560773486537202,0.0007408943454399909
NCT02549261,Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer,0.0007455218986951592,0.0007624282648946408
NCT02522910,An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC),0.0008714570078652257,0.0007966092502354057
NCT02546986,Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer,0.0008065461594214898,0.0007248181116681535
NCT02532062,The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer,0.000620733624893869,0.00045414866885905915
NCT02531464,Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung Cancer,0.0005894672013291395,0.0005893700846536825
NCT02531737,Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer,0.0006046819339787195,0.0008647093922002438
NCT02515435,The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer,0.0008123511604400956,0.0007419901317573554
NCT02515760,Tumor-specific T Cells in Lung Cancer,0.0005375682250759434,0.0005810678424389574
NCT02568033,Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer,0.0006351346189628796,0.0007768835967153425
NCT02528942,Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients,0.0005989985551770595,0.0006437710886375719
NCT02599454,Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer,0.000803632918352688,0.0008424421911603986
NCT02595944,Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer,0.0007688897021390546,0.0008634980929903498
NCT02595450,A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer,0.0006263556672659162,0.0007617721344744091
NCT02595840,"A Prospective, Multiparametric Biomarker Study to Identify Predictors of Treatment Response and Resistance in Patients With EGFR-mutated Non-small-cell Lung Cancer Receiving Maintenance Therapy With Either Afatinib or Pemetrexed With the AIO-TRK-0114 Study (MARBLE)",0.0006663087235076341,0.0006236764471197299
NCT02580708,A Phase 1/2 Study of the Safety and Efficacy of Rociletinib When Administered in Combination With Trametinib in Patients With Activating EGFR Mutation-positive Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0008531880705435663,0.0008241572006211249
NCT02590965,A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer,0.0007942179494066262,0.0006761980093973503
NCT02581943,Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer,0.0007364700660029243,0.0008576822754455649
NCT02581787,SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer,0.0006150614990629701,0.0007011191478583402
NCT02562027,SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer,0.0006319363279749637,0.0006115476802545766
NCT02575560,Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC),0.0006190666769688724,0.000710471883375809
NCT02597738,A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine,0.0005209888914497626,0.0005144767846562179
NCT02525653,Albumin-Bound Paclitaxel and Gemcitabine in Patients With Untreated Stage IV or Recurrent Squamous Cell Lung Cancers,0.0007184105248208969,0.0008131023499688067
NCT02525757,MPDL3280A With Chemoradiation for Lung Cancer,0.0009056471602784864,0.0006291478190746739
NCT02501668,The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease,0.0009034311467531367,0.00041220842935151176
NCT02503722,TORC1/2 Inhibitor INK128 and EGFR Inhibitor AZD9291 in Treating Patients With Advanced EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor,0.0007464826167516657,0.0008172622309597929
NCT02503358,Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer,0.0007566840654811322,0.0007970116717461608
NCT02523404,HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer,0.0005701930616898871,0.0009094780410665337
NCT00685750,Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma,0.0005983918618623808,0.0007223434407344385
NCT00687297,Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer,0.0007417380635554353,0.0006807686831248911
NCT00687986,Trial of Either Surgery or Stereotactic Radiotherapy for Early Stage (IA) Lung Cancer,0.0005134373301322983,0.0006366850746020345
NCT00621361,"Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients",0.0006317913125423049,0.0006575202168564826
NCT00676507,Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy,0.0006637970021778351,0.0007018450166023873
NCT00614484,Chemotherapy and Proton Radiation for the Treatment of Locally Advanced Lung Cancer,0.0006262465871630868,0.0008886044703072963
NCT00633568,Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer,0.0008302115809015604,0.0007019792086429322
NCT00633724,Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer,0.0009332578316398656,0.0007655632080390046
NCT00662311,"Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery",0.0006174012278421028,0.0008426537228767593
NCT00652340,APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer,0.00079466406990457,0.000757871728139383
NCT00636571,Feasibility of Exercise With Post-Op Lung Cancer Patients,0.0009061603718174922,0.0005657188748721871
NCT00673049,"Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer",0.000938454007658958,0.0006819373446611203
NCT00673283,Early Detection of Lung Cancer Via Bi-plane Correlation Chest Imaging,0.0005289550053667885,0.0003112361154632534
NCT00600821,A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.,0.0007068476438915024,0.0007248936223386428
NCT00600015,Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC),0.0006559230215044157,0.0006676512021230631
NCT00611598,DNA Repair and Genetic Susceptibility to Lung Cancer,0.0005228360230804808,0.00048313011207207484
NCT00683904,Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer,0.0007670121002568678,0.0009103536220932643
NCT00657423,Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC),0.0006629663210278042,0.0007046821593139352
NCT00681512,The Effect of Berries on Lung Cancer Tumors,0.0009265951916702065,0.0010493548760140163
NCT00682383,Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC),0.0006410114110254606,0.0005446246170185225
NCT00684385,An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck,0.0007047526530591866,0.0007009838642201316
NCT00603057,Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer,0.00045351017290398254,0.0006966406100948345
NCT00603538,"Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer",0.0006118810638677556,0.0007595450133686766
NCT00635596,"Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer",0.0006123423008893638,0.0005475251095193562
NCT00658580,Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer,0.0006440427584080916,0.0006904227994422095
NCT00656136,BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1),0.0007088676222290735,0.0006503916333441806
NCT00691132,Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers,0.0006442974243921545,0.00044218759326508373
NCT00639067,Breath Test for Early Detection of Lung Cancer,0.0006415096346786593,0.0006131827362355459
NCT00675597,"Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer",0.0007218347185095936,0.000715012897281424
NCT00690924,Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer,0.0005282186085645545,0.00041853811012924035
NCT00601796,"Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer",0.0006043745071669684,0.0006803563372286865
NCT00661778,A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer,0.0008511996197482466,0.0008201059800377326
NCT00693836,"Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region",0.0007240340393933961,0.0004850130090181937
NCT00622193,Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer,0.0010321614941224677,0.0014270484857237316
NCT00622349,Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer,0.00074514562309636,0.0007358906831651401
NCT00698815,Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer,0.0007281210036112329,0.0008158520769394441
NCT00666692,"A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)",0.0007280234052942456,0.0007853950376216771
NCT00686322,Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC),0.0005205250809162707,0.0006148259879421388
NCT00380666,The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer,0.0006437589063976438,0.0004901804088769578
NCT00398970,Utility of Endobronchial Ultrasound in the Investigation of Suspected Lung Cancer.,0.0006575606294734104,0.0005539080368619834
NCT00349492,A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer,0.0005187255111818837,0.0005847914188483482
NCT00349102,Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer,0.0006640373037622256,0.0005839353986501387
NCT00349089,Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy,0.0006900279330699758,0.0005335836431368178
NCT00338481,"""Red Morphine Drops"" for Symptomatic Treatment of Dyspnoea in Lung Cancer",0.0004677156813620655,0.0005105900702417302
NCT00373204,Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere),0.0006436968155501286,0.0007038872442391955
NCT00347412,Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer,0.0006804175129324369,0.0007430700672960685
NCT00303901,Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery,0.0006052706424295232,0.0007077810082838422
NCT00301119,Lung Cancer Biomarkers and Screening,0.0006567999213558488,0.0006022081075581459
NCT00340405,"Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China",0.0005193143926056464,0.0005277539490572289
NCT00340340,Genetic Epidemiology of Lung Cancer and Smoking,0.0005229354374611539,0.0004960164226804669
NCT00340847,Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer,0.00046052993474333243,0.0005736123510480215
NCT00368927,Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,0.0004667916926688567,0.0003861649639296257
NCT00315185,"Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer",0.0005947576476347951,0.0005905855920393774
NCT00326378,Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer,0.000744058259015276,0.0008426154630932412
NCT00363428,Lung Rehabilitation in Treating Patients With Chronic Obstructive Pulmonary Disease Who Are Undergoing Surgery for Lung Cancer,0.0006491527065578297,0.00044685267209997075
NCT00363805,Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease,0.0004660810301873414,0.00038206195022649325
NCT00345059,The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer,0.0007277187703551071,0.00074282420793882
NCT00345891,Quit Smoking Program for Lung Cancer Patients' Families (The Family Ties Project),0.000587865993579651,0.0006380619524754678
NCT00397124,The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients,0.0005973814257939532,0.000607539382276105
NCT00372788,"AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen",0.0007432677864434744,0.0008345378694696642
NCT00342836,Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer,0.0006342661228590596,0.0005844051081294794
NCT00342264,A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners,0.0005457451079652195,0.00044219943896954745
NCT00316225,Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen,0.0006302701455283158,0.0007555173869331656
NCT00365105,"Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer",0.0005457225735868923,0.00039492315138478355
NCT00365963,Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers,0.0009110670277141569,0.0005073077272328188
NCT00329472,Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer,0.0007369559678666313,0.0007845988380246442
NCT00313690,Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer,0.0006835304237207657,0.0006916863181600694
NCT00364624,Adrenal Function in Patients With Newly Diagnosed Lung Cancer,0.0006400049839283376,0.0005075644349746922
NCT00364780,Study of XL647 in Subjects With Non-Small-Cell Lung Cancer,0.0010459577960904261,0.0006602830301926067
NCT00325494,"A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer",0.0005079122168828901,0.0004814368245742667
NCT00330746,CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer,0.0006906639669096064,0.0008414691566482099
NCT00321893,Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer,0.0006361702863779544,0.0005115439873336707
NCT00391248,Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL),0.0006836975084237924,0.0006885227207199902
NCT00312377,ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer,0.0006537886462575828,0.000825175771124468
NCT00341380,Prevention of Tumor Spread Due to Lung Cancer Surgery,0.0005584862677193718,0.0006854217852149225
NCT00341835,Genetic Epidemiology of Lung Cancer,0.0006407251146598999,0.0005524640948917342
NCT00322751,Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer,0.0007047888995402738,0.0005987162701465913
NCT00300586,IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer,0.0008702575844178439,0.000672124038955532
NCT00390806,Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer,0.000503124700766501,0.0006332412376499929
NCT00339859,"DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer",0.0008992096430537476,0.0008224735636900916
NCT00324805,"Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery",0.0007529950209738112,0.0008450654700556157
NCT00791336,Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer,0.0006718834416033679,0.000968833623408429
NCT00723957,A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer,0.0006961084945504859,0.0007628383650508137
NCT00794547,Phase I/II Calcitriol in Lung Cancer,0.0008992087920730498,0.0008765556166600577
NCT00741247,Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA,0.0006383112256746074,0.00045737709602182474
NCT00741988,Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer,0.0006639378756243553,0.0007098954062454237
NCT00783705,Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia,0.0004672589028081012,0.0003953584010782339
NCT00749346,NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer,0.0006397411793040561,0.0007600330620587559
NCT00749567,Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer,0.000769165509446569,0.0008369648622031803
NCT00738881,Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007585782918153479,0.0008121464309515546
NCT00738387,A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer,0.0006993953482022719,0.0008613725095651354
NCT00733252,Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease,0.0005194726587981214,0.0004301597576587387
NCT00724581,Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer,0.0006012223579533696,0.0004754546500582903
NCT00735878,Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients With Advanced Lung Cancer,0.0007320804529698752,0.0007144216549892397
NCT00735696,A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer,0.0007491664176759763,0.0008184821178695446
NCT00798720,Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer,0.0006770166315681998,0.0008115719461808233
NCT00707304,Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer,0.001179452863618734,0.0010210109054250161
NCT00706862,Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer,0.0008310697139866149,0.0008333633683221567
NCT00751660,Screening Methods in Finding Lung Cancer Early in Current or Former Smokers,0.00046796578069566977,0.00039219665216112066
NCT00745160,Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes,0.0005822091873347643,0.0006202452514375589
NCT00702975,Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy,0.0008572154418663474,0.0008081807438395498
NCT00752076,Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment,0.000744057631385701,0.0009759021370736662
NCT00752115,Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer,0.0007685834774799141,0.0007547190582865668
NCT00717353,Genetic Polymorphisms in UGT1A6 and UGT2B7 in Asian Population: Association With Lung Cancer Phenotype,0.0005222381592757518,0.0004969370011611171
NCT00717795,Physical Activity Intervention for Lung Cancer Survivors,0.0005317791095160634,0.0005490475169753606
NCT00717002,Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study,0.000742821011632558,0.0007819102069872341
NCT00799240,MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer,0.0004624370976531308,0.0006543646625937361
NCT00701870,Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer,0.0008063205220918265,0.0008426323038828032
NCT00737867,Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer,0.0006634048384638372,0.0008091045551434426
NCT00732810,SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716),0.0007820085069670948,0.0007187937761136641
NCT00721981,An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy,0.0007830805800456874,0.0007994790053945813
NCT00708812,Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer,0.0007818730579065564,0.0006096177351773091
NCT00705549,"Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer",0.0007379034852472019,0.000768798560204133
NCT00425191,Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.,0.0006396390683756936,0.000719375527783945
NCT00425022,VATS Lobectomy for Clinical Stage IB or II Lung Cancer,0.0005022516773137949,0.0005837380351780738
NCT00466466,Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients,0.0006643442924397833,0.0007194244429365467
NCT00465907,"Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer",0.0005788972960697918,0.0007111063364369066
NCT00442754,Dendritic Cells in Lung Cancer,0.0009061865743784828,0.0005054227213408275
NCT00491699,Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer,0.0010459577960904261,0.000668214959244566
NCT00464282,Fluorine-18-α–Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer,0.0006665751281956842,0.0005980317224250855
NCT00457119,"Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients",0.0006320447025873002,0.0007064942035587056
NCT00492843,Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis,0.0005865560336235805,0.0005357443883497622
NCT00481624,Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia,0.000636333097862866,0.0005670615628442317
NCT00437749,A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer,0.0008512007847052744,0.000748070279674012
NCT00487760,African American Families and Lung Cancer Study,0.0010973335861418593,0.0005746115745683446
NCT00487669,Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC),0.0007100354712734332,0.00069863507729225
NCT00431015,"Phase I/II Safety Study of IPI-504 in Relapsed/Refractory Stage IIIb, or Stage IV Non-small Cell Lung Cancer (NSCLC)",0.0006913634023774856,0.0008772699582976563
NCT00409188,Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START),0.0006421944215973737,0.0006677080303415759
NCT00400803,Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer,0.0006372877887164561,0.0008162082085839278
NCT00444015,Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC),0.000680965035152566,0.0006287486687660898
NCT00440960,Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic,0.0005308134197550162,0.0005760202621057383
NCT00415363,"Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy",0.0006789434540908682,0.0007578408809410356
NCT00422500,Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer,0.0007043976176017716,0.0006990384895361678
NCT00473083,Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer,0.0004817017216783391,0.0004296178587896005
NCT00452413,A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer,0.0005740460894901157,0.0007942895053738814
NCT00452075,Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for Chemotherapy,0.0008281303654031557,0.0008740325811757877
NCT00402883,"Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer",0.0007518281125608393,0.0007805847638773313
NCT00424853,ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC),0.00052212591533455,0.0005712340768242298
NCT00462995,Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT),0.0005068213938946336,0.000809424203413766
NCT00490659,Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes,0.0005910461710701847,0.0006859836831271048
NCT00411593,Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC),0.0009700962538377151,0.000762035968916771
NCT00406302,Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC),0.0005012854634890586,0.0005182349325079996
NCT00432640,Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study),0.0005082119618662798,0.0006583418361164063
NCT00416689,Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer,0.0006070154543802223,0.000567846522137065
NCT00404365,Depression Screening in Patients With Lung Cancer,0.0007235263360163061,0.000535697186691036
NCT00434174,Safety of Everolimus and Pemetrexed in Lung Cancer Patients,0.0007336277006501382,0.0009425055166549471
NCT00471978,DNA Analysis of Blood and Tissue From Patients With Lung Cancer,0.0006366330511348375,0.0006288288703256255
NCT00460551,Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer,0.0004812266463670929,0.0006255811641276542
NCT00489996,Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer,0.0006478830624008445,0.0008729108904875558
NCT00482014,"A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer",0.0008105836154172362,0.0009418831272668916
NCT01886573,Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery,0.0006106494554682586,0.0008400528954466927
NCT01862081,"A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer",0.0007847894612921492,0.0007536616668003896
NCT01862770,Effect of Lung Cancer Diagnoses on Family Behaviors,0.0005307775580573893,0.0005983419502598275
NCT01888510,CT in Diagnosing Patients With Lung Cancer,0.0009172499571770258,0.0008487585173125674
NCT01888601,TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx),0.0009727725485424967,0.0008112285287415309
NCT01893580,Perioperative Rehabilitation in Operation for Lung Cancer,0.0006696470912347041,0.0006794205873642376
NCT01877811,"Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors",0.0006960408179692482,0.0006422233679026757
NCT01877902,Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System,0.0006556225159365007,0.0007359564871972742
NCT01852838,The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer,0.0006375299130371223,0.0005277730957300574
NCT01874678,A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer,0.0007925245442791306,0.0007381825071924437
NCT01899989,Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer,0.0009161810671310617,0.0007311627106825184
NCT01828099,LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer,0.000832810839898799,0.0009597519237375395
NCT01853826,An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s),0.0008276279216056625,0.0007728119816046787
NCT01883986,Supportive Care for Patients Newly Diagnosed With Lung Cancer,0.0007329888747988624,0.0005065838001082198
NCT01836575,Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2,0.0006440142850288313,0.0008106187140075055
NCT01836679,Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer,0.0006561429886602944,0.0008559919170070384
NCT01836341,Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation,0.0006093298210793893,0.0007579569766490344
NCT01846520,"Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers",0.0005587143407231183,0.0005700524924396428
NCT01855191,SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation,0.000765671477120547,0.000627886064951493
NCT01809210,Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer,0.0006352752781439978,0.0006716843943938873
NCT01880528,Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer,0.0006640568604622153,0.0007320412832551075
NCT01861197,Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer,0.0007165497152202151,0.0011042744002298034
NCT01829113,Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer,0.000620075845798815,0.0008789757729066203
NCT01823094,CTP Imaging of Lung Cancer,0.0009104852282471363,0.0003707652621594461
NCT01865903,Nutritional Problems and Changes in Body Composition in Patients With Non-small Cell Lung Cancer (LEKS),0.0007040853710015178,0.0004922400553601139
NCT01881906,Exercise in Advanced Stage Lung Cancer Patients,0.0007293965163060019,0.0006003815033676814
NCT01881516,Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）,0.0006366042614587412,0.0006426698659322219
NCT01859338,"MRI, Cone Beam CT, and Fan Beam CT in Detecting Soft Tissue in Patients With Prostate and Lung Cancer Undergoing Radiation Therapy",0.0005915748188447603,0.0006240918266403397
NCT01822496,Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer,0.0007320778519758813,0.0009083458439597688
NCT01871454,Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers,0.000614942896938173,0.0005963394336459107
NCT01887769,Body Composition Analysis for Patient With Lung Cancer Using Computed Tomography Image Analysis,0.0006310185951937399,0.0005936002550601218
NCT01885754,Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer,0.0007240544394838996,0.0006590844471123572
NCT01837329,Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer,0.00066455645492562,0.0007589616397115292
NCT01854684,Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery,0.0007572265410378667,0.0007698828643614734
NCT01898156,"Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer",0.0005470660321599824,0.0005913913526839895
NCT01851161,Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy,0.0005982464950458686,0.0006207803584401239
NCT01802021,Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients,0.0005835131160011269,0.0007236495573632552
NCT01969955,Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer,0.0005892315651757309,0.000899715818686426
NCT01995188,A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer,0.0006422494384745778,0.0006673571778136831
NCT01980212,Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer,0.000687192895214585,0.0007664661276271124
NCT01980849,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer,0.0006025679701764132,0.0004902444263719569
NCT01977209,Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression,0.0004884125599641625,0.0005853954327728218
NCT01937637,Improving Management of Breathlessness in Patients With Lung Cancer,0.0007248262904642148,0.0006388404656833225
NCT01950156,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer,0.0007190764063643394,0.0007042518380566282
NCT01952860,Hatha Yoga in Lung Cancer Couples,0.0009003584338823972,0.0006410442135218004
NCT01911507,INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer,0.0009329440812234043,0.0007986675250332184
NCT01911325,Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients,0.0008483666166949329,0.0007800559621495038
NCT01967095,Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer,0.0006202254582804166,0.0006078004557947899
NCT01909752,Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer,0.0007306497630453562,0.0008146468487421894
NCT01982955,Tepotinib With Gefitinib in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC),0.0006611857403468767,0.0008298896476811299
NCT01924416,Lung Cancer Information Study (LCIS-R01),0.0006206435375652086,0.00042927688845268986
NCT01958931,Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer,0.00045387420258954724,0.0007243293043987325
NCT01914120,the Quality of Life Assessment of Lung Cancer Patients in China,0.0009034311467531367,0.0007210352088029366
NCT01914458,Image Discovering Early Lung Cancer Project,0.0006410963399474411,0.00037950219213213256
NCT01918761,Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC),0.0007887542722307284,0.0007545194498991151
NCT01963195,Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy,0.0006884484223107337,0.0009197082404790638
NCT01990261,A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment,0.0008289866016759243,0.0009237880279487423
NCT01968941,Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients,0.000612718272673982,0.0005811499495032673
NCT01933828,Treatment of Early Stage Lung Cancer by VATS Versus OPEN Lobectomy,0.000534336129161925,0.0005996867037794297
NCT01928836,Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China,0.0007346621177363843,0.0007049182282620294
NCT01930474,Analysis of Plasma Tumor DNA in Lung Cancer Patients,0.0007375614717318857,0.0007137599064337871
NCT01987232,"Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Subjects With Previously Untreated Extensive Stage Small-cell Lung Cancer",0.0005318387385092439,0.0008100585685786764
NCT01943578,Value of Physical Capacity Tests in Lung Cancer,0.0005281416973991139,0.0004373042873942496
NCT01998425,Circulating Fibrocytes in Non-small Cell Lung Cancer.,0.0013112651325000633,0.0005985132267573401
NCT01998126,Combination Checkpoint Inhibitor Plus Erlotinib or Crizotinib for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer,0.0006010698012984593,0.0006217227137182952
NCT01929200,Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation,0.0007295339155444589,0.0008767868405524372
NCT01993810,Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer,0.0007679351810566178,0.0008526981723064679
NCT01993550,Telephone Support Program for Lung Cancer Patients and Their Family Caregivers,0.0005858939991299001,0.00041225889106726493
NCT01991418,Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC),0.0006631190423915111,0.0006642918510417373
NCT01912625,"Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery",0.0007403425071833844,0.0009294477808987636
NCT01955343,Immune Response in Lung Cancer,0.0006477053851365796,0.0006519461627030637
NCT01935336,Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers,0.000724887489107454,0.0007443036717393395
NCT01935947,Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer,0.0007788252483028897,0.0008201047893684207
NCT01951586,Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer,0.0006485194767179288,0.0006718746806678594
NCT01951469,Gefitinib With or Without Pemetrexed/Cisplatin in Brain Metastases From Non-small Cell Lung Cancer,0.0006121365280081494,0.000594456278367307
NCT01951755,Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC),0.000858851775398416,0.0009307611337194223
NCT01951482,Pemetrexed/Cisplatin With or Without Bevacizumab in Brain Metastases From Non Squamous Non-small Cell Lung Cancer,0.0006152075762386799,0.0005874179717799255
NCT01925625,Early Cancer Detection Test - Lung Cancer Scotland,0.0006407181567348911,0.0005115505546094606
NCT01999673,Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer,0.0006674620810809863,0.0007420601492451294
NCT01999881,Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients,0.0006443945780444157,0.0005645421808587964
NCT01999985,Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC),0.000667567889217404,0.0007669179524658389
NCT01999621,Determinants of Intensity of Care of Lung Cancer Patients With Organ Failure,0.0009038207513285233,0.0005190556374924608
NCT01949701,Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*02 Disease Controlled Advanced Non-small Cell Lung Cancer,0.0007190764063643394,0.0006839794831515473
NCT01949181,"Blood, Hair and Lung Concentrations of Metals and Metalloids in Patients With Lung Cancer or Chronic Obstructive Pulmonary Disease",0.0005660086768049726,0.000813691030233926
NCT01949259,Rapid Learning for Lung Cancer,0.0008986078023327957,0.0005919235374560364
NCT01941303,Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease,0.0007503847272140559,0.0007670062064871931
NCT01931306,Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC),0.0008279203849202835,0.0008818335761895856
NCT01964157,"An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement",0.0008095757195701643,0.0007996636273257473
NCT01985113,Correlation Research of Thioredoxin Reductase in Lung Cancer,0.00089919091688757,0.0005905726810767611
NCT01939210,Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy,0.000575329824369211,0.0005752317933255021
NCT01938456,Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer,0.0006136108394754217,0.0007295105354540808
NCT02630615,Circulating Tumor Cells (CTC) in Lung Cancer,0.0009032417088488564,0.0006448298637862005
NCT02619266,The Safety and Effect Study of Acupuncture for Anorexia in Patients With Gastrointestinal Tract and Lung Cancers,0.0006305537442338497,0.0007185437553790356
NCT02619448,Concurrent Chemotherapy and Accelerated Hypofractionated Radiation in Medically Inoperable Non-small Cell Lung Cancer,0.0006930569058931547,0.0007820835214586097
NCT02696863,Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study,0.0006224209551848771,0.00046707116389730377
NCT02696525,Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients,0.0006161395418671165,0.0007733424614137168
NCT02686775,The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer Patients,0.000666168329320088,0.0006904462996707095
NCT02665390,Percutaneous Cryoablation Peripheral Lung Cancer,0.0008991931120766214,0.0009906822759262804
NCT02612532,Lung Cancer Indicator Detection,0.0006449685830150403,0.000730751867494615
NCT02644252,Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer,0.000641587874571299,0.0005792657704287932
NCT02688686,Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases,0.0008688616971521576,0.0008001865584462646
NCT02693080,CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy,0.0007441212473131971,0.0007989301251393226
NCT02608411,TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES),0.0006967617103754949,0.0009268947811493518
NCT02664792,Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer,0.0005313845134478901,0.0004196710318410874
NCT02638090,Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC),0.0007716032681569218,0.0007114220555116033
NCT02655536,"Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial",0.0005560791246426851,0.0007048147944708098
NCT02671045,Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer,0.0006595655764414647,0.0006203986034685349
NCT02663492,Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients,0.0008003776395496162,0.0007203229148809117
NCT02642042,Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer,0.0007250571205878396,0.0008597365443829094
NCT02613637,Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project,0.000628678007273725,0.000774689164967007
NCT02666755,Novel Detection System for Lung Cancer Curative Effect Monitoring,0.0006469324114168156,0.0007462057540861315
NCT02679963,Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer,0.0007580106696437359,0.000796491651648128
NCT02603627,"Prevalence of COPD in Our Lung Cancer Population, Compared to Controls",0.0017169554734706223,0.0009728927417370629
NCT02603367,COMFORT Caregiver Intervention in Improving Communication and Reducing Distress in Caregivers of Patients With Lung Cancer,0.0006339823796538205,0.0005150626915130998
NCT02629523,Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA,0.0006605538955436025,0.0009203300675188294
NCT02629458,A Study to Determine the Feasibility and Acceptability of Conducting a Phase III Randomised Controlled Trial Comparing Stereotactic Ablative Radiotherapy With Surgery in paTients With Peripheral Stage I nOn-small Cell Lung Cancer cOnsidered Higher Risk of Complications From Surgical Resection,0.0006814047414001339,0.0008320462429668218
NCT02691299,A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer,0.0007942179494066262,0.0006806283259620139
NCT02695550,"Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer",0.0008159942715031463,0.0009231036411704631
NCT02675842,Investigation of Cannabis for Pain and Inflammation in Lung Cancer,0.0004730427369731058,0.0005806365410163822
NCT02607423,Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery,0.000754980222684557,0.0008353033789573684
NCT02676050,Visualising c-MET and Activated Neutrophils in Lung Cancer,0.0008986078023327957,0.00047237471631698263
NCT02617186,Robotic Lobectomy vs. Thoracoscopic Lobectomy for Early Stage Lung Cancer,0.000561441534281164,0.0004376683770067779
NCT02699229,Non-linear Multimodal Microendoscopy for Lung Cancer Pathology,0.0006371466613411748,0.0005090678946764163
NCT02699606,"A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma",0.000677940311317275,0.0007072787440765395
NCT02681549,Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer,0.0006065420830456452,0.0007807663601524249
NCT02673814,Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer,0.0006539497448383324,0.0007422908648793101
NCT02658032,Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP),0.0006742499536045365,0.0005969309531589294
